Pharmacy Benefit Updates
The changes described below apply to members whose plans include pharmacy benefits. To find out which formulary (list of covered medications) your plan uses, sign in to MyBlue.
UPDATE - Effective January 1, 2025, Changes to the Blue Cross Blue Shield of Massachusetts Formulary and Medical Policy Updates
Effective January 1, 2025, we’re updating our formulary (list of covered medications) for medical plans with pharmacy benefits, as well as Medex®´1 plans with a three-tier pharmacy benefit. As part of this update, certain medications may:
- No longer be covered (exceptions may be granted)
- Be excluded from coverage (exceptions won’t be granted)
- Have new quantity or dosing limits
- Switch tiers
- Require prior authorization and/or step therapy
- No longer be covered under the medical benefit and will only be covered under the pharmacy benefit
We’re also making medical policy changes, effective January 1, 2025.
1. This doesn’t include Medex®´ 2 plans with Blue MedicareRx (PDP) prescription drug coverage.
Medications no longer covered starting January 1, 2025
After carefully reviewing each medication’s cost and its clinically appropriate covered alternatives, we’ve removed the medications listed below from our formulary. However, a doctor may request an exception if the medication prescribed is medically necessary. If the exception is approved, you’ll pay the highest-tier cost.
Medication Class | Medication Name | Covered Alternative |
Acne - Oral treatments | Isotretinoin 25mg and 35mg | Isotretinoin 10mg, 20mg, 30mg, 40mg |
Acne – Tretinoins | Retin-A Gel products | Tretinoin Gel products |
Antimalarial/Antirheumatic – Oral | Hydroxychloroquine 100mg, 300mg, 400mg | Hydroxychloroquine 200mg |
Antimigraine – CGRP Injectables | Aimovig | Ajovy Emgality |
Antimigraine - Nasal | Migranal spray | Dihydroergotamine spray |
Antispasmodics | Librax | Chlordiazepoxide/Clidinium |
Fibric Acid Derivatives | Fenofibrate 40mg and 120mg | Fenofibrate 48mg and 145mg |
Genitourinary - Urinary Antispasmodics (OAB) | Myrbetriq | Mirabegron |
GLP-1 receptor Agonists | Victoza | Liraglutide |
Immunoglobulin | Cuvitru1 | Cutaquig Hizentra |
Immunomodulators | Yusimry1 | Hadlima Humira Simlandi |
Insulins - Basal | Basaglar | Lantus Toujeo Max Toujeo Max Solostar |
Insulins - Rapid Acting | Humalog 100U/ml Humalog Jr. 100U/ml Humalog Kwik Pen 100U/ml Humalog Kwik Pen 200U/ml Humalog 50/50 Humalog 50/50 Kwik Pen Humalog 75/25 Kwik Pen Humalog 75/25 suspension Humalog Tempo 100U/ml | Novolog Novolog Mix Novolog 70/30 |
Insulins - Rapid Acting | Humulin 70/30 Humulin 70/30 Kwik Pen Humulin-N U-100 Humulin-N U-100 Kwik Pen Humulin-R U-100 | Novolin-N Novolin-R Novolin 70/30 |
Pegfilgrastim Agents | Neulasta Neulasta On-Pro Ziextenzo | Fulphila Udenyca Udenyca On-Body |
Short Acting Human Growth Hormones | Nutropin AQ | Genotropin Humatrope |
1. We’ll continue to cover this medication if you’re already taking it. However, you’ll pay your plan’s highest-tier cost.
Medications excluded from coverage
The following medications will be excluded from our pharmacy benefit as of January 1, 2025. You’ll be responsible for the full cost of these medications when filling a prescription at the pharmacy. This change will apply to all commercial plans, group Medex®´ plans with pharmacy benefits, and Managed Blue for Seniors. Formulary exceptions won’t be accepted for these medications.
Medication Class | Medication Name |
Multivitamins | Folivane-F Integra-F |
Medications with new quality care dosing (QCD) limits
To make sure that the quantity and dose of a medication meet the Food and Drug Administration, manufacturer, and clinical recommendations, the QCD limit for the below medications has changed.
Medication Class | Medication Name | Previous Coverage Limit | New Coverage Limit |
Autoimmune Agents | Skyrizi 150mg/ml | 1 syringe per 28 days | 1 syringe per 84 days |
Skyrizi 180mg/1.2ml | 1 syringe per 28 days | 1 syringe per 56 days | |
Skyrizi Pen 150mg/ml | 1 pen per 28 days | 1 pen per 84 days | |
Stelara 45mg/0.5ml | 1 syringe per 28 days | 1 syringe per 84 days | |
Stelara 45mg/0.5ml | 1 vial per 28 days | 1 vial per 84 days | |
Stelara 90mg/ml | 2 syringes per 28 days | 1 syringe per 56 days | |
Enbrel 50mg/ml | 8 syringes per 28 days | 4 syringes per 28 days | |
Enbrel 50mg/ml Mini | 8 syringes per 28 days | 4 syringes per 28 days | |
Enbrel 50mg/ml SureClick | 8 syringes per 28 days | 4 syringes per 28 days | |
Taltz 80mg/ml | 4 syringes per 28 days | 1 syringe per 28 days | |
Taltz 80mg/ml | 4 autoinjectors per 28 days | 1 autoinjector per 28 days | |
Tremfya 100mg/ml | 1 syringe per 28 days | 1 syringe per 56 days | |
Tremfya 100mg/ml | 1 autoinjector per 28 days | 1 autoinjector per 56 days |
Medications switching tiers
When the cost of a medication changes, we may move the medication to a different tier. The medications listed below are moving to a lower or higher tier under certain pharmacy plans, and what you pay for the following medications may increase or decrease.
Medication Class | Medication Name | 2025 Tier | |||
---|---|---|---|---|---|
For members with a three-tier pharmacy benefit | For members with a four-tier pharmacy benefit | For members with a five-tier pharmacy benefit | For members with a six-tier pharmacy benefit | ||
Auto-immune agents | Velsipity2 | Tier 2a | Tier 3a | Tier 4a | Tier 5a |
Antilipemics - PCSK9 Inhibitors | Leqvio2 | Tier 3b | Tier 4c | Tier 3b | Tier 4c |
Central Nervous System - Antipsychotics (long acting) | Abilify Asimtufii | Tier 2a | Tier 3a | Tier 2a | Tier 3a |
Gastrointestinal - Irritable Bowel Syndrom | Viberzi2 | Tier 2a | Tier 3a | Tier 2a | Tier 3a |
Immunologic Agents | Infliximab2 | Tier 3b | Tier 4c | Tier 5d | Tier 6e |
2. This medication also requires prior authorization.
- This medication was previously non-covered.
- This medication was previously covered at Tier 2.
- This medication was previously covered at Tier 3.
- This medication was previously covered at Tier 4.
- This medication was previously covered at Tier 5.
- This medication was previously covered at Tier 6.
Medications requiring prior authorization
For certain medications, your doctor must first obtain approval before we cover them. The following medication now requires prior authorization:
Medication Name |
Viberzi3 |
3. If you’re currently filling prescriptions for this medication, you won’t need prior authorization.
Medical policy updates
Blue Cross medical policies are developed by using evidence-based information to define the technologies, procedures, and treatments that are considered medically necessary, or not medically necessary, or investigational. We use pharmacy medical policies to describe how we cover certain medications. The policies listed below are being updated. Changes include:
- Step therapy policy changes that apply when the medication within the pharmacy medical policy is newly prescribed for members. With step therapy, you may need to try a less expensive (lower step) medication before we’ll cover a more expensive (higher step) medication. Your doctor can request an exception if needed.
- Prior authorization requirements for specific medications to ensure that your prescribing doctor has determined that a medication is necessary to treat you, based on specific medical standards.
For This Policy | Update |
Immune Modulating Drugs Policy (004) | Velsipity will move from the “Non-Formulary, Non-Preferred Drugs” section to the “Formulary Non-Preferred Drugs” section for the treatment of Ulcerative Colitis. |
Medical Benefit Prior Authorization Medication List (034) (linked to medical Policy 033 – Medical Utilization Management (MED UM) & Pharmacy Prior Authorization Policy) | This policy will be updated to include Cuvitru, Jesduvroq, and Spevigo. Prior authorization will be required for new and existing prescriptions to be covered under the medical benefit. |
Injectable Specialty Medication Coverage Policy (071) | This policy will be updated to include Adlyxin, Bydureon, Byetta, Liraglutide, Mounjaro, Ozempic, Saxenda, Soliqua, Tanzeum, Trulicity, Victoza, Wegovy, Xultophy, and Zepbound. Starting January 1, 2025, these medications will only be covered through the pharmacy benefit. Coverage through the medical benefit will end December 31, 2024. |
Supportive Care Treatments for Patients with Cancer (105) | This policy will be updated to include Udenyca, Udenyca On Body, and Fulphila. These medications will be required to be used prior to the approval of Neulasta, Neulasta On Pro, and Ziextenzo. |
Immunoglobulins Policy (310) | This policy will be updated to include Cutaquig and Hizentra. These medications will be required to be used prior to the approval of Cuvitru. |
Quality Care Dosing (621B) | Policy will be updated to change quantity limits of following immunologic agents: Enbrel, Skyrizi, Stelara, Taltz, and Tremfya. |
Looking for more information?
For more information about any of these medications, go to the Medication Lookup tool.
Questions?
If you have any questions, contact your account executive.
Effective January 1, 2025, Changes to the Blue Cross Blue Shield of Massachusetts Formulary and Medical Policy Updates
Effective January 1, 2025, we’re updating our formulary (list of covered medications) for medical plans with pharmacy benefits, as well as Medex®´* plans with a three-tier pharmacy benefit. As part of this update, certain medications may:
- No longer be covered (exceptions may be granted)
- Be excluded from coverage (exceptions won’t be granted)
- Have new quantity or dosing limits
- Switch tiers
- Require prior authorization and/or step therapy
- No longer be covered under the medical benefit and will only be covered under the pharmacy benefit
We’re also making medical policy changes, effective January 1, 2025.
Complete details about these changes will be available by October 31, 2024 at bluecrossma.org/pharmacy_updates under the Blue Cross Formulary tab.
Questions?
If you have any questions, call Team Blue at the Member Service number on the front of your ID card.
*This doesn’t include Medex®´ 2 plans with Blue MedicareRx (PDP) prescription drug coverage.
UPDATE - Effective January 1, 2025, Changes to the Blue Cross Blue Shield of Massachusetts Formulary and Medical Policy Updates
Effective January 1, 2025, we’re updating our formulary (list of covered medications) for medical plans with pharmacy benefits, as well as Medex®´1 plans with a three-tier pharmacy benefit. As part of this update, certain medications may:
- No longer be covered (exceptions may be granted)
- Be excluded from coverage (exceptions won’t be granted)
- Have new quantity or dosing limits
- Switch tiers
- Require prior authorization and/or step therapy
- No longer be covered under the medical benefit and will only be covered under the pharmacy benefit
We’re also making medical policy changes, effective January 1, 2025.
1. This doesn’t include Medex®´ 2 plans with Blue MedicareRx (PDP) prescription drug coverage.
Medications no longer covered starting January 1, 2025
After carefully reviewing each medication’s cost and its clinically appropriate covered alternatives, we’ve removed the medications listed below from our formulary. However, a doctor may request an exception if the medication prescribed is medically necessary. If the exception is approved, you’ll pay the highest-tier cost.
Medication Class | Medication Name | Covered Alternative |
Acne - Oral treatments | Isotretinoin 25mg and 35mg | Isotretinoin 10mg, 20mg, 30mg, 40mg |
Acne – Tretinoins | Retin-A Gel products | Tretinoin Gel products |
Antimalarial/Antirheumatic – Oral | Hydroxychloroquine 100mg, 300mg, 400mg | Hydroxychloroquine 200mg |
Antimigraine – CGRP Injectables | Aimovig | Ajovy Emgality |
Antimigraine - Nasal | Migranal spray | Dihydroergotamine spray |
Antispasmodics | Librax | Chlordiazepoxide/Clidinium |
Fibric Acid Derivatives | Fenofibrate 40mg and 120mg | Fenofibrate 48mg and 145mg |
Genitourinary - Urinary Antispasmodics (OAB) | Myrbetriq | Mirabegron |
GLP-1 receptor Agonists | Victoza | Liraglutide |
Immunoglobulin | Cuvitru1 | Cutaquig Hizentra |
Immunomodulators | Yusimry1 | Hadlima Humira Simlandi |
Insulins - Basal | Basaglar | Lantus Toujeo Max Toujeo Max Solostar |
Insulins - Rapid Acting | Humalog 100U/ml Humalog Jr. 100U/ml Humalog Kwik Pen 100U/ml Humalog Kwik Pen 200U/ml Humalog 50/50 Humalog 50/50 Kwik Pen Humalog 75/25 Kwik Pen Humalog 75/25 suspension Humalog Tempo 100U/ml | Novolog Novolog Mix Novolog 70/30 |
Insulins - Rapid Acting | Humulin 70/30 Humulin 70/30 Kwik Pen Humulin-N U-100 Humulin-N U-100 Kwik Pen Humulin-R U-100 | Novolin-N Novolin-R Novolin 70/30 |
Pegfilgrastim Agents | Neulasta Neulasta On-Pro Ziextenzo | Fulphila Udenyca Udenyca On-Body |
Short Acting Human Growth Hormones | Nutropin AQ | Genotropin Humatrope |
1. We’ll continue to cover this medication if you’re already taking it. However, you’ll pay your plan’s highest-tier cost.
Medications excluded from coverage
The following medications will be excluded from our pharmacy benefit as of January 1, 2025. You’ll be responsible for the full cost of these medications when filling a prescription at the pharmacy. This change will apply to all commercial plans, group Medex®´ plans with pharmacy benefits, and Managed Blue for Seniors. Formulary exceptions won’t be accepted for these medications.
Medication Class | Medication Name |
Multivitamins | Folivane-F Integra-F |
Medications with new quality care dosing (QCD) limits
To make sure that the quantity and dose of a medication meet the Food and Drug Administration, manufacturer, and clinical recommendations, the QCD limit for the below medications has changed.
Medication Class | Medication Name | Previous Coverage Limit | New Coverage Limit |
Autoimmune Agents | Skyrizi 150mg/ml | 1 syringe per 28 days | 1 syringe per 84 days |
Skyrizi 180mg/1.2ml | 1 syringe per 28 days | 1 syringe per 56 days | |
Skyrizi Pen 150mg/ml | 1 pen per 28 days | 1 pen per 84 days | |
Stelara 45mg/0.5ml | 1 syringe per 28 days | 1 syringe per 84 days | |
Stelara 45mg/0.5ml | 1 vial per 28 days | 1 vial per 84 days | |
Stelara 90mg/ml | 2 syringes per 28 days | 1 syringe per 56 days | |
Enbrel 50mg/ml | 8 syringes per 28 days | 4 syringes per 28 days | |
Enbrel 50mg/ml Mini | 8 syringes per 28 days | 4 syringes per 28 days | |
Enbrel 50mg/ml SureClick | 8 syringes per 28 days | 4 syringes per 28 days | |
Taltz 80mg/ml | 4 syringes per 28 days | 1 syringe per 28 days | |
Taltz 80mg/ml | 4 autoinjectors per 28 days | 1 autoinjector per 28 days | |
Tremfya 100mg/ml | 1 syringe per 28 days | 1 syringe per 56 days | |
Tremfya 100mg/ml | 1 autoinjector per 28 days | 1 autoinjector per 56 days |
Medications switching tiers
When the cost of a medication changes, we may move the medication to a different tier. The medications listed below are moving to a lower or higher tier under certain pharmacy plans, and what you pay for the following medications may increase or decrease.
Medication Class | Medication Name | 2025 Tier | |||
---|---|---|---|---|---|
For members with a three-tier pharmacy benefit | For members with a four-tier pharmacy benefit | For members with a five-tier pharmacy benefit | For members with a six-tier pharmacy benefit | ||
Auto-immune agents | Velsipity2 | Tier 2a | Tier 3a | Tier 4a | Tier 5a |
Antilipemics - PCSK9 Inhibitors | Leqvio2 | Tier 3b | Tier 4c | Tier 3b | Tier 4c |
Central Nervous System - Antipsychotics (long acting) | Abilify Asimtufii | Tier 2a | Tier 3a | Tier 2a | Tier 3a |
Gastrointestinal - Irritable Bowel Syndrom | Viberzi2 | Tier 2a | Tier 3a | Tier 2a | Tier 3a |
Immunologic Agents | Infliximab2 | Tier 3b | Tier 4c | Tier 5d | Tier 6e |
2. This medication also requires prior authorization.
- This medication was previously non-covered.
- This medication was previously covered at Tier 2.
- This medication was previously covered at Tier 3.
- This medication was previously covered at Tier 4.
- This medication was previously covered at Tier 5.
- This medication was previously covered at Tier 6.
Medications requiring prior authorization
For certain medications, your doctor must first obtain approval before we cover them. The following medication now requires prior authorization:
Medication Name |
Viberzi3 |
3. If you’re currently filling prescriptions for this medication, you won’t need prior authorization.
Medical policy updates
Blue Cross medical policies are developed by using evidence-based information to define the technologies, procedures, and treatments that are considered medically necessary, or not medically necessary, or investigational. We use pharmacy medical policies to describe how we cover certain medications. The policies listed below are being updated. Changes include:
- Step therapy policy changes that apply when the medication within the pharmacy medical policy is newly prescribed for members. With step therapy, you may need to try a less expensive (lower step) medication before we’ll cover a more expensive (higher step) medication. Your doctor can request an exception if needed.
- Prior authorization requirements for specific medications to ensure that your prescribing doctor has determined that a medication is necessary to treat you, based on specific medical standards.
For This Policy | Update |
Immune Modulating Drugs Policy (004) | Velsipity will move from the “Non-Formulary, Non-Preferred Drugs” section to the “Formulary Non-Preferred Drugs” section for the treatment of Ulcerative Colitis. |
Medical Benefit Prior Authorization Medication List (034) (linked to medical Policy 033 – Medical Utilization Management (MED UM) & Pharmacy Prior Authorization Policy) | This policy will be updated to include Cuvitru, Jesduvroq, and Spevigo. Prior authorization will be required for new and existing prescriptions to be covered under the medical benefit. |
Injectable Specialty Medication Coverage Policy (071) | This policy will be updated to include Adlyxin, Bydureon, Byetta, Liraglutide, Mounjaro, Ozempic, Saxenda, Soliqua, Tanzeum, Trulicity, Victoza, Wegovy, Xultophy, and Zepbound. Starting January 1, 2025, these medications will only be covered through the pharmacy benefit. Coverage through the medical benefit will end December 31, 2024. |
Supportive Care Treatments for Patients with Cancer (105) | This policy will be updated to include Udenyca, Udenyca On Body, and Fulphila. These medications will be required to be used prior to the approval of Neulasta, Neulasta On Pro, and Ziextenzo. |
Immunoglobulins Policy (310) | This policy will be updated to include Cutaquig and Hizentra. These medications will be required to be used prior to the approval of Cuvitru. |
Quality Care Dosing (621B) | Policy will be updated to change quantity limits of following immunologic agents: Enbrel, Skyrizi, Stelara, Taltz, and Tremfya. |
Looking for more information?
For more information about any of these medications, go to the Medication Lookup tool.
Questions?
If you have any questions, contact your account executive.
Effective January 1, 2025, Changes to the Blue Cross Blue Shield of Massachusetts Formulary and Medical Policy Updates
Effective January 1, 2025, we’re updating our formulary (list of covered medications) for medical plans with pharmacy benefits, as well as Medex®´* plans with a three-tier pharmacy benefit. As part of this update, certain medications may:
- No longer be covered (exceptions may be granted)
- Be excluded from coverage (exceptions won’t be granted)
- Have new quantity or dosing limits
- Switch tiers
- Require prior authorization and/or step therapy
- No longer be covered under the medical benefit and will only be covered under the pharmacy benefit
We’re also making medical policy changes, effective January 1, 2025.
Complete details about these changes will be available by October 31, 2024 at bluecrossma.org/pharmacy_updates under the Blue Cross Formulary tab.
Questions?
If you have any questions, call Team Blue at the Member Service number on the front of your ID card.
*This doesn’t include Medex®´ 2 plans with Blue MedicareRx (PDP) prescription drug coverage.
Effective May 15, 2024, Select Diabetes and Weight-Loss Medications No Longer Available Through the Mail Service Pharmacy
Effective May 15, 2024, due to a medication shortage, you won’t be able to fill the following diabetes and weight-loss medications in 90-day supplies through the mail service pharmacy:
Diabetes Medications | Weight-Loss Medications |
• Mounjaro • Trulicity | • Wegovy • Saxenda |
These medications will continue to be available in 30-day supplies through in-network retail pharmacies. If you fill these medications through the mail service pharmacy, you should have received a letter from CVS Customer Care with more information about the change.
If you want to find an in-network pharmacy that’s convenient to you, sign in to MyBlue, then select Find a Pharmacy under My Medications. You can also call Team Blue Member Service at the number on your ID card.
Questions?
If you have any questions, call CVS Customer Care at 1-877-817-0477 (TTY: 711).
On August 1, 2024, AllianceRx Walgreens Specialty Pharmacy will become Walgreens Specialty Pharmacy
AllianceRx Walgreens Specialty Pharmacy delivers specialty pharmacy services to individuals with complex medical conditions. On August 1, 2024, they’re changing their name to Walgreens Specialty Pharmacy. You don’t need to take any action if you’re currently using this pharmacy. They’ll continue to fill your covered prescriptions — just under a new name.
To reach Walgreens Specialty Pharmacy:
- Phone: 1-888-347-3416
- Fax: 1-877-231-8302
Questions?
If you have any questions, call Team Blue at the Member Service number on your ID card.
Acaria Health Is Leaving Our Specialty Pharmacy Network
On July 1, 2024, Acaria Health will be leaving our specialty pharmacy network.
If you fill your prescriptions through Acaria Health, you can complete your current course of treatment with Acaria Health, but treatments starting on or after July 1, 2024 will need to be filled through through Accredo, AllianceRx Walgreens Pharmacy, or CVS Specialty in order to be covered. If you’re currently using Acaria Health, you should have received a letter from us about next steps.
This change applies to plans with the Blue Cross Blue Shield of Massachusetts formulary, and the Standard Control with Advanced Control Specialty Formulary. For more information about specialty medications, use our Medication Lookup tool.
Questions?
If you have any questions, call Team Blue at the Member Service number on your ID card.
UPDATE - Effective July 1, 2024, Changes to the Blue Cross Blue Shield of Massachusetts Formulary and Medical Policy Updates
Effective July 1, 2024, we’re updating our formulary (list of covered medications) for medical plans with pharmacy benefits, as well as Medex®´* plans with a three-tier pharmacy benefit. As part of this update, certain medications may:
- No longer be covered (exceptions may be granted)
- Switch tiers
- Require prior authorization and/or step therapy
We’re also making medical policy changes, effective July 1, 2024.
*This doesn’t include Medex®´ 2 plans with Blue MedicareRx (PDP) prescription drug coverage.
Medications No Longer Covered Starting July 1, 2024
After carefully reviewing each medication’s cost and its clinically appropriate covered alternatives, we’ve removed the medications listed below from our formulary. However, a doctor may request an exception if the medication prescribed is medically necessary. If the exception is approved, you’ll pay the highest-tier cost.
Medication Class | Medication Name | Covered Alternative |
---|---|---|
Anaphylaxis agents |
Epi-Pen |
Epinephrine Autoinjectors |
Benign prostatic hyperplasia |
Avodart |
Dutasteride |
Botulinum toxins |
Daxxify |
Botox |
Cancer (supportive treatments) |
Nivestym |
Granix |
Fulphila |
Neulasta |
|
Cataplexy |
Xyrem |
Lumryz |
Electrolyte disorders |
Samsca |
Tolvaptan |
Gallstone solubilizing agents |
Reltone 200 mg and 400 mg |
Ursodiol 250 mg and 500 mg |
Gout (treatment agents) |
Allopurinol 200 mg |
Allopurinol 100 mg and 300 mg |
Growth hormones |
Sogroya |
Skytrofa |
Hepatitis C treatments |
Vosevi |
Epclusa |
Hereditary angioedema |
Firazyr* |
Icatibant |
Immunomodulators for skin conditions |
Adbry |
Dupixent |
Metabolic modifiers |
Carbaglu* |
Carglumic Acid |
Movement disorders |
Xenazine |
Tetrabenazine |
Oncology |
Afinitor |
Everolimus |
Targretin* |
Bexarotene |
|
PCSK9 inhibitors |
Praluent |
Repatha |
Progestins |
Prometrium |
Progesterone (Micronized) |
Pulmonary arterial hypertension |
Adcirca |
Alyq |
Letairis* |
Ambrisentan |
|
Pulmonary fibrosis |
Esbriet* |
Pirfenidone |
Testosterones |
Aveed* |
Testosterone cypionate |
*If you’re currently taking any of these medications, you’ll be allowed coverage so you can continue using them. You’ll pay the highest copay amount at checkout.
Medications Switching Tiers
When the cost of a medication changes, we may move the medication to a different tier. The medications listed below are moving to a lower or higher tier under certain pharmacy plans, and what you pay for the following medications may increase or decrease.
Medication Class | Medication Name | 2024 Tier | |||
---|---|---|---|---|---|
For members with a three-tier pharmacy benefit | For members with a four-tier pharmacy benefit | For members with a five-tier pharmacy benefit | For members with a six-tier pharmacy benefit | ||
Anti-migraine |
Qulipta |
Tier 2a |
Tier 3a |
Tier 2a |
Tier 3a |
Zavzpret |
Tier 3b |
Tier 4c |
Tier 3b |
Tier 4c |
|
Auto-immune agents |
Kevzara |
Tier 3b |
Tier 4c |
Tier 5d |
Tier 6e |
Hepatitis C treatments |
ledipasvir/sofosbuvir |
Tier 2a |
Tier 3a |
Tier 4a |
Tier 5a |
Women’s health |
Myfembree |
Tier 2a |
Tier 3a |
Tier 2a |
Tier 3a |
a. This medication was previously non-covered.
b. This medication was previously covered at Tier 2.
c. This medication was previously covered at Tier 3.
d. This medication was previously covered at Tier 4.
e. This medication was previously covered at Tier 5.
f. This medication was previously covered at Tier 6.
Medical Policy Updates
Blue Cross medical policies are developed by using evidence-based information to define the technologies, procedures, and treatments that are considered medically necessary, or not medically necessary, or investigational. We use pharmacy medical policies to describe how we cover certain medications. The policies listed below are being updated. Changes include:
- Step therapy policy changes that apply when the medication within the pharmacy medical policy is newly prescribed for members. With step therapy, you may need to try a less expensive (lower step) medication before we’ll cover a more expensive (higher step) medication. Your doctor can request an exception if needed.
- Prior authorization requirements for specific medications to ensure that your doctor has determined that a medication is necessary to treat you, based on specific medical standards.
For This Policy | Update |
---|---|
Botulinum Toxin Injections (006) | Adding Daxxify, Myobloc, and Xeomin as non-covered medications. |
Immunomodulators for Skin Conditions Policy (010) | Adding Adbry and Cibinqo as non-covered medications. Updating Rinvoq’s medical necessity criteria for coverage. For members 12 years or older with moderate-to-severe atopic dermatitis (eczema), we’ll cover the medication when they’ve had an inadequate response to trying a corticosteroid and calcineurin inhibitor. |
Anti-Migraine Policy (021) | Qulipta is moving from non-covered to preferred and requires the use of two covered alternatives before approval. This will apply to members newly prescribed these medications. |
Medical Utilization Management (MED UM) & Pharmacy Prior Authorization Policy (033) | Updating Dupixent’s medical necessity criteria for coverage. For members six months or older with moderate-to-severe atopic dermatitis (eczema), we’ll cover the medication when they’ve had an inadequate response to trying a corticosteroid and calcineurin inhibitor. |
Phosphodiesterase Type-5 Inhibitors for Pulmonary Arterial Hypertension (036) | This policy will be retired on July 1, 2024. |
Benign Prostatic Hyperplasia (040) | This policy will be retired on July 1, 2024. |
Supportive Care Treatments for Patients with Cancer (105) | Adding Fulphila, Fylnetra, Nivestym, Nyvepria, Releuko, Rolvedon, Stimufend, and Udenyca as non-covered medications. |
Hepatitis C Medication Management (344) | Adding Vosevi as a non-covered medication and Ledipasvir/Sofosbuvir and Sofosbuvir/Velpatasvir as covered medications. |
Topical Ocular Hydrating Agents Policy (426) | Prior authorization will be required for new prescriptions of Lacrisert to treat dry eye disease. |
Looking for More Information?
For more information about any of these medications, go to our Medication Lookup tool.
Questions?
If you have any questions, call Team Blue at the Member Service number on your ID card.
Effective July 1, 2024, Upcoming Changes to the Blue Cross Blue Shield of Massachusetts Formulary and Medical Policy Updates
Effective July 1, 2024, we’re updating our formulary (list of covered medications) for medical plans with pharmacy benefits, as well as Medex®´* plans with a three-tier pharmacy benefit. As part of this update, certain medications may:
- No longer be covered (exceptions may be granted)
- Be excluded from coverage (exceptions won’t be granted)
- Switch tiers
- Require prior authorization and/or step therapy
- No longer be covered under the pharmacy benefit and will only be covered under the medical benefit
We’re also making medical policy changes, effective July 1, 2024.
Complete details about these changes will be available by May 31, 2024. Check back at that time.
Questions?
If you have any questions, call Team Blue at the Member Service number on your ID card.
*This doesn’t include Medex®´ 2 plans with Blue MedicareRx (PDP) prescription drug coverage.
UPDATE: Effective April 1, 2024, Upcoming Medical Policy Change for the Blue Cross Blue Shield of Massachusetts Formulary
Effective April 1, 2024, we're updating the following medical policy to provide coverage for more affordable medication options. This change affects our formulary (list of covered medications) for medical plans with pharmacy benefits, as well as Medex®´1 plans with a three-tier pharmacy benefit.
For This Policy | Update |
---|---|
Immune Modulating Drugs Policy (004) | Remicade will be non-covered. Inflectra and Avsola will continue to be covered as preferred alternatives and Renflexis and Infliximab as non-preferred alternatives. Prior authorization will continue to be required. Amjevita will be non-covered. Humira, Hadlima, and Yusimry will continue to be covered as preferred alternatives and Adalimumab-adbm, Adalimumab-adaz, Adalimumab-fkjp, and Hyrimoz (Cordavis product) will be covered as non-preferred alternatives. If Amjevita is approved through an exception, it will be covered at a higher tier and have a higher copay. Prior authorization will continue to be required. |
Questions?
If you have any questions, call Team Blue at the Member Service number on your ID card.
1. This doesn’t include Medex®´2 plans with Blue MedicareRx (PDP) prescription drug coverage.
Effective April 1, 2024, Upcoming Medical Policy Change for the Blue Cross Blue Shield of Massachusetts Formulary
Effective April 1, 2024, we're updating a medical policy for our formulary (list of covered medications) for medical plans with pharmacy benefits, as well as Medex®´1 plans with a three-tier pharmacy benefit.
Complete details about these changes will be available by January 11, 2024. Check back at that time.
Questions?
If you have any questions, call Team Blue at the Member Service number on your ID card.
1. This doesn’t include Medex®´ 2 plans with Blue MedicareRx (PDP) prescription drug coverage.
Some Previously Announced Medical Policy Changes for the Blue Cross Blue Shield of Massachusetts Formulary Are Being Delayed
The medical policy changes below, which were previously announced to be effective January 1, 2024, are being delayed to March 1, 2024.
For This Policy | Update |
---|---|
Immune Modulating Drugs Policy (004) | Dosing and frequency of use will be required as part of prior authorization for the following medications: Actemra (non-preferred), Avsola (preferred), Orencia (non-preferred), Inflectra (preferred), Infliximab (non-preferred), Remicade (non-preferred), Renflexis (non-preferred). These medications are covered under the pharmacy benefit, and the medical benefit for providers that signed the medical benefit amendment to buy and bill. |
Injectable Asthma Medications (017) | Dosing and frequency of use will be required as part of prior authorization for Xolair in order to be covered under the medical benefit. |
Medication Utilization Management (MED UM) & Pharmacy Prior Authorization (033) | Dosing and frequency of use will be required as part of prior authorization for the following medications in order for them to be covered under the medical benefit: Prolia, Tepezza, Xgeva. |
Vascular Endothelial Growth Factor (VEGF) Inhibitors Step Therapy (092) – Medical Benefit | Dosing and frequency of use will be required as part of prior authorization for Aflibercept (Eylea) in order to be covered under the medical benefit. |
Soliris, Ultomiris, Myasthenia Gravis, and Neuromyelitis Optica Policy (093) | Dosing and frequency of use will be required as part of prior authorization for Soliris in order to be covered under the medical benefit. |
Nononcologic Uses of Rituximab (123) | Dosing and frequency of use will be required as part of prior authorization for the following medications in order for them to be covered under the medical benefit: Riabni, Rituxan, Ruxience, Truxima. |
Entyvio (Vedolizumab) Policy (162) | Dosing and frequency of use will be required as part of prior authorization for Entyvio in order to be covered under the medical benefit. |
Questions?
If you have any questions, call Team Blue at the Member Service number on your ID card.
AllianceRx Walgreens Pharmacy Will Join Our Specialty Pharmacy Network
On January 1, 2024, AllianceRx Walgreens Pharmacy will join our specialty pharmacy network. Specialty pharmacies provide medications that are used to treat certain complex health conditions. For more information about specialty medications, use our Medication Lookup tool.
This change applies to plans with the Blue Cross Blue Shield of Massachusetts Formulary, and the Standard Control with Advanced Control Specialty Formulary.
Questions?
If you have any questions, call Team Blue at the Member Service number on your ID card.
UPDATE - Effective January 1, 2024, Upcoming Changes to the Blue Cross Blue Shield of Massachusetts Formulary and Medical Policy Updates
Effective January 1, 2024, we’re updating our formulary (list of covered medications) for medical plans with pharmacy benefits, as well as Medex®´1 plans with a three-tier pharmacy benefit. As part of this update, certain medications may:
- No longer be covered (exceptions may be granted)
- Have new quantity or dosing limits
- Be required to be filled at an in-network specialty pharmacy
- Require prior authorization and/or step therapy
- No longer be covered under the medical benefit and will only be covered under the pharmacy benefit
We’re also making medical policy changes, effective January 1, 2024.
1. This doesn’t include Medex®´ 2 plans with Blue MedicareRx (PDP) prescription drug coverage.
Medications No Longer Covered Starting January 1, 2024
After carefully reviewing each medication’s cost and its clinically appropriate covered alternatives, we’ve removed the medications listed below from our formulary. However, a doctor may request an exception if the medication prescribed is medically necessary. If the exception is approved, you’ll pay the highest-tier cost.
Medication Class | Medication Name | Covered Alternative |
---|---|---|
Antibiotics |
Doxycycline Hyclate 75 mg and 150 mg |
Doxycycline 50 mg and 100 mg |
Bisphosphonates |
Actonel |
Risedronate |
Continuous Glucose Monitors* |
Enlite |
Dexcom |
Iron Reducers |
Exjade |
Deferasirox |
Ferriprox |
Deferiprone |
|
Non-Steroidal Anti-Inflammatory Drugs (NSAIDs)* |
Indocin suspension |
Naproxen suspension |
Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) |
Diclofenac 25 mg capsules |
Diclofenac 50 mg |
Diclofenac 2% suspension |
Diclofenac 1.5% |
|
Ketoprofen 200 mg ER |
Ketoprofen |
|
Meloxicam Submicronized |
Meloxicam |
|
Oral Corticosteroids* |
Prednisolone 5 mg |
Prednisone |
Steroid Inhalers |
Flovent Diskus |
Fluticasone Propionate |
Steroid Combination Inhalers |
Symbicort |
Breyna |
Topical Antimicrobials |
Noritate |
Metronidazole |
Topical Antifungal - Onychomycosis |
Tavaborole |
Ciclopirox |
Tyrosine Metabolism Inhibitor |
Orfadin |
Nitisinone |
Urinary Retention Agents |
Uroxatral |
Alfuzosin ER |
*If you’re currently using these medications, you’ll be allowed to continue and will pay your highest copay amount.
Medications with New Quality Care Dosing (QCD) Limit
To make sure that the quantity and dose of a medication meet the Food and Drug Administration, manufacturer, and clinical recommendations, the medication listed below now requires QCD.
Medication Class | Medication Name | New Coverage Limit |
---|---|---|
COVID-19 treatment |
Paxlovid |
One (1) carton per fill (enough to treat per FDA), and one (1) fill for 5 days every 30 days |
Medications Required to Be Filled at an In-Network Specialty Pharmacy
Effective January 1, 2024, the following medications will only be covered when filled at an in-network specialty pharmacy:
Acetadote |
Dichlorphenamide |
Lynparza |
Synarel |
Arcalyst |
Emflaza |
Lytgobi |
Tazicef |
Asparlas |
Estradiol Valerate |
Marqibo |
Testosterone Enanthate |
Bicillin L-A |
Evomela |
Mektovi |
Tiopronin |
Braftovi |
Fortaz |
Mugard |
Tlando |
Calquence |
Gavreto |
Nitisinone |
Uptravi |
Carglumic Acid |
Inbrija |
Nityr |
Ventavis |
Cometriq |
Ingrezza |
Onpattro |
Veozah |
Cutaquig |
Ingrezza Initiation Pack |
Portrazza |
Vincasar PFS |
Cystaran |
Jatenzo |
Qutenza |
Vyepti |
Daraprim |
Jayvygtor |
Reblozyl |
Vyxeos |
Deferoxamine Mesylate |
Jynarque |
Rimso-50 |
Yondelis |
Delestrogen |
Kanuma |
Rolvedon |
Yonsa |
Depo-Estradiol |
Koselugo |
Romidepsin |
Zejula |
Desferal Mesylate |
Kyzatrex |
Sajazir |
Zydelig |
Prior Authorization Now Required for Briumvi and Ocrevus
Effective January 1, 2024, prior authorization will be required for new and existing prescriptions of Briumvi and Ocrevus in order to be covered by your plan.
The medications will be covered under our medical benefit when administered at a health care provider’s office, by a home health care provider, by a home infusion therapy provider, or in an outpatient hospital and dialysis setting. They’ll be covered under our pharmacy benefit when they’re filled at a specialty pharmacy.
Prior authorization won’t be required when Briumvi and Ocrevus are administered in inpatient, surgical day care, urgent care centers or emergency department settings.
Coverage Changes for Certain Medications Being Removed from Our Medical Benefit
Effective January 1, 2024, the following specialty medications will no longer be covered by our medical benefit. They’ll only be covered under our pharmacy benefit when filled at an in-network specialty pharmacy. Prior authorization is still required for these medications. This change will apply to all medical plans, except Medicare Advantage, Medical Supplemental plans, and Federal Employee Program plans.
- Simponi Aria
- Stelara
If you’re currently filling these specialty medications at an in-network specialty pharmacy under our pharmacy benefit, you won’t experience a break in coverage. If you’re currently filling these medications under our medical benefit and have pharmacy coverage with Blue Cross Blue Shield of Massachusetts, you’ll receive a detailed letter about the coverage change, along with next steps. If you don’t have pharmacy coverage from Blue Cross Blue Shield of Massachusetts, we’ll also send you a letter about the change, with additional information about contacting your prescription plan to find out if you’re covered for these medications.
Medical Policy Updates
Blue Cross medical policies are developed by using evidence-based information to define the technologies, procedures, and treatments that are considered medically necessary, or not medically necessary, or investigational. We use pharmacy medical policies to describe how we cover certain medications. The policies listed below are being updated. Changes include:
- Step therapy policy changes that apply when the medication within the pharmacy medical policy is newly prescribed for members. With step therapy, you may need to try a less expensive (lower step) medication before we’ll cover a more expensive (higher step) medication. Your doctor can request an exception if needed.
- Prior authorization requirements for specific medications to ensure your doctor has determined that a medication is necessary to treat you, based on specific medical standards.
For This Policy | Update |
---|---|
Immune Modulating Drugs Policy (004) |
This policy will be updated to reflect the removal of medical benefit coverage for Simponi Aria and Stelara mentioned above.
Dosing and frequency of use will be required as part of prior authorization for the following medications: Actemra (non-preferred), Avsola (preferred), Orencia (non-preferred), Inflectra (preferred), Infliximab (non-preferred), Remicade (non-preferred), Renflexis (non-preferred). These medications are covered under the pharmacy benefit, and the medical benefit for providers that signed the medical benefit amendment to buy and bill. |
Injectable Asthma Medications (017) |
Dosing and frequency of use will be required as part of prior authorization for Xolair in order to be covered under the medical benefit. |
Medication Utilization Management (MED UM) & Pharmacy Prior Authorization (033) |
This medical policy will be updated to include Briumvi and Ocrevus. Prior authorization will be required for new and existing prescriptions to be covered under the medical or pharmacy benefit.
Tysabri currently requires prior authorization under the medical benefit and will require prior authorization under the pharmacy benefit, effective January 1, 2024.
Dosing and frequency of use will be required as part of prior authorization for the following medications in order for them to be covered under the medical benefit: Prolia, Tepezza, Xgeva. |
Bisphosphonates, Oral (058) |
This policy will be retired on January 1, 2024. |
Injectable Specialty Medication Coverage (071) |
This policy will be updated to include Simponi Aria and Stelara. |
Vascular Endothelial Growth Factor (VEGF) Inhibitors Step Therapy (092) – Medical Benefit |
This policy will be updated to remove Alymsys, MVASI, Vegzelma and Zirabev.
This policy is changing to a prior authorization policy and all Step 2 and Step 3 medications under this policy will transition from a step therapy to a prior authorization requirement. Prior authorization will be required for new prescription for any medication under this policy. |
Soliris, Ultomiris, Myasthenia Gravis, and Neuromyelitis Optica Policy (093) |
Dosing and frequency of use will be required as part of prior authorization for Soliris in order to be covered under the medical benefit. |
Quality Care Cancer Program (Medical Oncology) (099) |
Riabni will move from preferred to non-preferred and Truxima will move from non-preferred to preferred for new prescriptions. Prior authorization through Carelon Medical Benefit Management, as part of the Quality Care Cancer Program, will continue to be required. |
Supportive Care Treatments for Patients with Cancer (105) |
Fulphila will move from preferred to non-preferred for new prescriptions. |
Nononcologic Uses of Rituximab (123) |
Dosing and frequency of use will be required as part of prior authorization for the following medications in order for them to be covered under the medical benefit: Riabni, Rituxan, Ruxience, Truxima. |
Entyvio (Vedolizumab) Policy (162) |
Dosing and frequency of use will be required as part of prior authorization for Entyvio in order to be covered under the medical benefit. |
Multiple Sclerosis, Prior Auth & Step Policy (839) |
Prior authorization will be required for new prescriptions of Kesimpta.
The following medications will no longer require step therapy but will require prior authorization to be covered. This applies to new prescriptions for these medications: Avonex, Betaseron, Extavia, Plegridy, Rebif. |
Looking for More Information?
For more information about any of these medications, go to the Medication Lookup tool.
Questions?
If you have any questions, call Team Blue at the Member Service number on the front of your ID card.
Effective January 1, 2024, Upcoming Changes to the Blue Cross Blue Shield of Massachusetts Formulary and Medical Policy Updates
Effective January 1, 2024, we’re updating our formulary (list of covered medications) for medical plans with pharmacy benefits, as well as Medex®´* plans with a three-tier pharmacy benefit. As part of this update, certain medications may:
- No longer be covered (exceptions may be granted)
- Have new quantity or dosing limits
- Require prior authorization and/or step therapy
- No longer be covered under the medical benefit and will only be covered under the pharmacy benefit
We’re also making medical policy changes, effective January 1, 2024.
Complete details about these changes will be available by October 31, 2023. Check back at that time.
Questions?
If you have any questions, call Team Blue at the Member Service number on the front of your ID card.
*This doesn’t include Medex®´2 plans with Blue MedicareRxTM (PDP) prescription drug coverage.
Some Previously Announced Medical Policy Changes for the Blue Cross Blue Shield of Massachusetts Formulary Are Being Delayed
The medical policy changes below, which were previously announced to be effective January 1, 2024, are being delayed to March 1, 2024.
For This Policy | Update |
---|---|
Immune Modulating Drugs Policy (004) |
Dosing and frequency of use will be required as part of prior authorization for the following medications: Actemra (non-preferred), Avsola (preferred), Orencia (non-preferred), Inflectra (preferred), Infliximab (non-preferred), Remicade (non-preferred), Renflexis (non-preferred). These medications are covered under the pharmacy benefit, and the medical benefit for providers that signed the medical benefit amendment to buy and bill. |
Injectable Asthma Medications (017) |
Dosing and frequency of use will be required as part of prior authorization for Xolair in order to be covered under the medical benefit. |
Medication Utilization Management (MED UM) & Pharmacy Prior Authorization (033) |
Dosing and frequency of use will be required as part of prior authorization for the following medications in order for them to be covered under the medical benefit: Prolia, Tepezza, Xgeva. |
Vascular Endothelial Growth Factor (VEGF) Inhibitors Step Therapy (092) – Medical Benefit |
Dosing and frequency of use will be required as part of prior authorization for Aflibercept (Eylea) in order to be covered under the medical benefit. |
Soliris, Ultomiris, Myasthenia Gravis, and Neuromyelitis Optica Policy (093) |
Dosing and frequency of use will be required as part of prior authorization for Soliris in order to be covered under the medical benefit. |
Nononcologic Uses of Rituximab (123) |
Dosing and frequency of use will be required as part of prior authorization for the following medications in order for them to be covered under the medical benefit: Riabni, Rituxan, Ruxience, Truxima. |
Entyvio (Vedolizumab) Policy (162) |
Dosing and frequency of use will be required as part of prior authorization for Entyvio in order to be covered under the medical benefit. |
Questions?
If you have any questions, call Team Blue at the Member Service number on your ID card.
UPDATE - Effective January 1, 2024, Upcoming Changes to the Blue Cross Blue Shield of Massachusetts Formulary and Medical Policy Updates
Effective January 1, 2024, we’re updating our formulary (list of covered medications) for medical plans with pharmacy benefits, as well as Medex®´1 plans with a three-tier pharmacy benefit. As part of this update, certain medications may:
- No longer be covered (exceptions may be granted)
- Have new quantity or dosing limits
- Be required to be filled at an in-network specialty pharmacy
- Require prior authorization and/or step therapy
- No longer be covered under the medical benefit and will only be covered under the pharmacy benefit
We’re also making medical policy changes, effective January 1, 2024.
1. This doesn’t include Medex®´ 2 plans with Blue MedicareRx (PDP) prescription drug coverage.
Medications No Longer Covered Starting January 1, 2024
After carefully reviewing each medication’s cost and its clinically appropriate covered alternatives, we’ve removed the medications listed below from our formulary. However, a doctor may request an exception if the medication prescribed is medically necessary. If the exception is approved, you’ll pay the highest-tier cost.
Medication Class | Medication Name | Covered Alternative |
---|---|---|
Antibiotics |
Doxycycline Hyclate 75 mg and 150 mg |
Doxycycline 50 mg and 100 mg |
Bisphosphonates |
Actonel |
Risedronate |
Continuous Glucose Monitors* |
Enlite |
Dexcom |
Iron Reducers |
Exjade |
Deferasirox |
Ferriprox |
Deferiprone |
|
Non-Steroidal Anti-Inflammatory Drugs (NSAIDs)* |
Indocin suspension |
Naproxen suspension |
Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) |
Diclofenac 25 mg capsules |
Diclofenac 50 mg |
Diclofenac 2% suspension |
Diclofenac 1.5% |
|
Ketoprofen 200 mg ER |
Ketoprofen |
|
Meloxicam Submicronized |
Meloxicam |
|
Oral Corticosteroids* |
Prednisolone 5 mg |
Prednisone |
Steroid Inhalers |
Flovent Diskus |
Fluticasone Propionate |
Steroid Combination Inhalers |
Symbicort |
Breyna |
Topical Antimicrobials |
Noritate |
Metronidazole |
Topical Antifungal - Onychomycosis |
Tavaborole |
Ciclopirox |
Tyrosine Metabolism Inhibitor |
Orfadin |
Nitisinone |
Urinary Retention Agents |
Uroxatral |
Alfuzosin ER |
*If you’re currently using these medications, you’ll be allowed to continue and will pay your highest copay amount.
Medications with New Quality Care Dosing (QCD) Limit
To make sure that the quantity and dose of a medication meet the Food and Drug Administration, manufacturer, and clinical recommendations, the medication listed below now requires QCD.
Medication Class | Medication Name | New Coverage Limit |
---|---|---|
COVID-19 treatment |
Paxlovid |
One (1) carton per fill (enough to treat per FDA), and one (1) fill for 5 days every 30 days |
Medications Required to Be Filled at an In-Network Specialty Pharmacy
Effective January 1, 2024, the following medications will only be covered when filled at an in-network specialty pharmacy:
Acetadote |
Dichlorphenamide |
Lynparza |
Synarel |
Arcalyst |
Emflaza |
Lytgobi |
Tazicef |
Asparlas |
Estradiol Valerate |
Marqibo |
Testosterone Enanthate |
Bicillin L-A |
Evomela |
Mektovi |
Tiopronin |
Braftovi |
Fortaz |
Mugard |
Tlando |
Calquence |
Gavreto |
Nitisinone |
Uptravi |
Carglumic Acid |
Inbrija |
Nityr |
Ventavis |
Cometriq |
Ingrezza |
Onpattro |
Veozah |
Cutaquig |
Ingrezza Initiation Pack |
Portrazza |
Vincasar PFS |
Cystaran |
Jatenzo |
Qutenza |
Vyepti |
Daraprim |
Jayvygtor |
Reblozyl |
Vyxeos |
Deferoxamine Mesylate |
Jynarque |
Rimso-50 |
Yondelis |
Delestrogen |
Kanuma |
Rolvedon |
Yonsa |
Depo-Estradiol |
Koselugo |
Romidepsin |
Zejula |
Desferal Mesylate |
Kyzatrex |
Sajazir |
Zydelig |
Prior Authorization Now Required for Briumvi and Ocrevus
Effective January 1, 2024, prior authorization will be required for new and existing prescriptions of Briumvi and Ocrevus in order to be covered by your plan.
The medications will be covered under our medical benefit when administered at a health care provider’s office, by a home health care provider, by a home infusion therapy provider, or in an outpatient hospital and dialysis setting. They’ll be covered under our pharmacy benefit when they’re filled at a specialty pharmacy.
Prior authorization won’t be required when Briumvi and Ocrevus are administered in inpatient, surgical day care, urgent care centers or emergency department settings.
Coverage Changes for Certain Medications Being Removed from Our Medical Benefit
Effective January 1, 2024, the following specialty medications will no longer be covered by our medical benefit. They’ll only be covered under our pharmacy benefit when filled at an in-network specialty pharmacy. Prior authorization is still required for these medications. This change will apply to all medical plans, except Medicare Advantage, Medical Supplemental plans, and Federal Employee Program plans.
- Simponi Aria
- Stelara
If you’re currently filling these specialty medications at an in-network specialty pharmacy under our pharmacy benefit, you won’t experience a break in coverage. If you’re currently filling these medications under our medical benefit and have pharmacy coverage with Blue Cross Blue Shield of Massachusetts, you’ll receive a detailed letter about the coverage change, along with next steps. If you don’t have pharmacy coverage from Blue Cross Blue Shield of Massachusetts, we’ll also send you a letter about the change, with additional information about contacting your prescription plan to find out if you’re covered for these medications.
Medical Policy Updates
Blue Cross medical policies are developed by using evidence-based information to define the technologies, procedures, and treatments that are considered medically necessary, or not medically necessary, or investigational. We use pharmacy medical policies to describe how we cover certain medications. The policies listed below are being updated. Changes include:
- Step therapy policy changes that apply when the medication within the pharmacy medical policy is newly prescribed for members. With step therapy, you may need to try a less expensive (lower step) medication before we’ll cover a more expensive (higher step) medication. Your doctor can request an exception if needed.
- Prior authorization requirements for specific medications to ensure your doctor has determined that a medication is necessary to treat you, based on specific medical standards.
For This Policy | Update |
---|---|
Immune Modulating Drugs Policy (004) |
This policy will be updated to reflect the removal of medical benefit coverage for Simponi Aria and Stelara mentioned above.
Dosing and frequency of use will be required as part of prior authorization for the following medications: Actemra (non-preferred), Avsola (preferred), Orencia (non-preferred), Inflectra (preferred), Infliximab (non-preferred), Remicade (non-preferred), Renflexis (non-preferred). These medications are covered under the pharmacy benefit, and the medical benefit for providers that signed the medical benefit amendment to buy and bill. |
Injectable Asthma Medications (017) |
Dosing and frequency of use will be required as part of prior authorization for Xolair in order to be covered under the medical benefit. |
Medication Utilization Management (MED UM) & Pharmacy Prior Authorization (033) |
This medical policy will be updated to include Briumvi and Ocrevus. Prior authorization will be required for new and existing prescriptions to be covered under the medical or pharmacy benefit.
Tysabri currently requires prior authorization under the medical benefit and will require prior authorization under the pharmacy benefit, effective January 1, 2024.
Dosing and frequency of use will be required as part of prior authorization for the following medications in order for them to be covered under the medical benefit: Prolia, Tepezza, Xgeva. |
Bisphosphonates, Oral (058) |
This policy will be retired on January 1, 2024. |
Injectable Specialty Medication Coverage (071) |
This policy will be updated to include Simponi Aria and Stelara. |
Vascular Endothelial Growth Factor (VEGF) Inhibitors Step Therapy (092) – Medical Benefit |
This policy will be updated to remove Alymsys, MVASI, Vegzelma and Zirabev.
This policy is changing to a prior authorization policy and all Step 2 and Step 3 medications under this policy will transition from a step therapy to a prior authorization requirement. Prior authorization will be required for new prescription for any medication under this policy. |
Soliris, Ultomiris, Myasthenia Gravis, and Neuromyelitis Optica Policy (093) |
Dosing and frequency of use will be required as part of prior authorization for Soliris in order to be covered under the medical benefit. |
Quality Care Cancer Program (Medical Oncology) (099) |
Riabni will move from preferred to non-preferred and Truxima will move from non-preferred to preferred for new prescriptions. Prior authorization through Carelon Medical Benefit Management, as part of the Quality Care Cancer Program, will continue to be required. |
Supportive Care Treatments for Patients with Cancer (105) |
Fulphila will move from preferred to non-preferred for new prescriptions. |
Nononcologic Uses of Rituximab (123) |
Dosing and frequency of use will be required as part of prior authorization for the following medications in order for them to be covered under the medical benefit: Riabni, Rituxan, Ruxience, Truxima. |
Entyvio (Vedolizumab) Policy (162) |
Dosing and frequency of use will be required as part of prior authorization for Entyvio in order to be covered under the medical benefit. |
Multiple Sclerosis, Prior Auth & Step Policy (839) |
Prior authorization will be required for new prescriptions of Kesimpta.
The following medications will no longer require step therapy but will require prior authorization to be covered. This applies to new prescriptions for these medications: Avonex, Betaseron, Extavia, Plegridy, Rebif. |
Looking for More Information?
For more information about any of these medications, go to the Medication Lookup tool.
Questions?
If you have any questions, call Team Blue at the Member Service number on the front of your ID card.
Effective January 1, 2024, Upcoming Changes to the Blue Cross Blue Shield of Massachusetts Formulary and Medical Policy Updates
Effective January 1, 2024, we’re updating our formulary (list of covered medications) for medical plans with pharmacy benefits, as well as Medex®´* plans with a three-tier pharmacy benefit. As part of this update, certain medications may:
- No longer be covered (exceptions may be granted)
- Have new quantity or dosing limits
- Require prior authorization and/or step therapy
- No longer be covered under the medical benefit and will only be covered under the pharmacy benefit
We’re also making medical policy changes, effective January 1, 2024.
Complete details about these changes will be available by October 31, 2023. Check back at that time.
Questions?
If you have any questions, call Team Blue at the Member Service number on the front of your ID card.
*This doesn’t include Medex®´2 plans with Blue MedicareRxTM (PDP) prescription drug coverage.
UPDATE - Effective July 1, 2023, Upcoming Changes to the Blue Cross Blue Shield of Massachusetts Formulary and Medical Policy Updates
Effective July 1, 2023, we’re updating our formulary (list of covered medications) for medical plans with pharmacy benefits, as well as Medex®´1 plans with a three-tier pharmacy benefit. As part of this update, certain medications may:
- No longer be covered (exceptions may be granted)
- Have new quantity or dosing limits
- Switch tiers
- Require prior authorization and/or step therapy
- No longer be covered under the medical benefit and will only be covered under the pharmacy benefit
We’re also making medical policy changes, effective July 1, 2023.
1. This doesn’t include Medex®´ 2 plans with Blue MedicareRx (PDP) prescription drug coverage.
Medications No Longer Covered Starting July 1, 2023
After carefully reviewing each medication’s cost and its clinically appropriate covered alternatives, we’ve removed the medications listed below from our formulary. However, a doctor may request an exception if the medication prescribed is medically necessary. If the exception is approved, you’ll pay the highest-tier cost.
Medication Class | Medication Name | Covered Alternative |
---|---|---|
Topical Anti-psoriatic | calcipotriene - betamethasone dipropionate topical suspension Taclonex suspension |
clobetasol shampoo |
Prenatal Vitamins | Atabex EC Atabex OB Azesco Bal-Care DHA C-Nate DHA CitraNatal CitraNatal 90 DHA CitraNatal Assure CitraNatal B-Calm CitraNatal Bloom CitraNatal DHA CitraNatal Harmony Complete Natal DHA pak CompleteNate chew Co-natal FA Concept DHA Concept OB Duet DHA 400 mis 25-1-400 Duet DHA Balanced EnBrace HR Folivane-OB cap Jenliva Koshr prenatal tab 30-1mg M-Natal Plus tab Multi-Mac tab Mynatal tab Mynatal tab advance Mynate 90 tab plus Natachew chew Natalvit tab 75-1mg NeevoDHA Neonatal Complete Neonatal Complete tab Neonatal DHA Neonatal FE tab Neonatal Plus Neonatal Plus tab 27-1mg Nestabs tab Nestabs DHA pak Nestabs one cap Niva-plus OB Complete/cap DHA OB Complete one OB Complete petite OB Complete tab OB Complete tab premier Obstetrix One cap 38-1-225 Obstetrix DHA pak Obstetrix EC tab O-Cal tab prenatal One Vite plus PNV-DHA cap docusate PNV-omega cap PNV tabs tab 29-1mg PR Natal 400 pak PR Natal EC 400 pak Pregen DHA cap Pregenna tab Premesis Rx tab Prena1 chew Prena1 Pearl cap Prena1 True Prenaissance cap Prenaissance Plus cap Prenara cap prenatal Prenatal 19 chew 29-1mg Prenatal+FE tab 29-1mg Prenatal tab 27-1mg Prenatal vitamin tab low iron Prenate Prenate AM tab 1mg Prenate chew 0.6-0.4 Prenate DHA Prenate Elite tab Prenate Enhance cap Prenate Essential Prenate Mini Prenate Restore cap Prenatal-u cap 106.5-1 Prenatal tab 27-1mg Prenatal tab plus Prenatvite Complete tab Prenatvite Plus tab Prenatvite Rx tab Preplus tab 27-1mg Pretab tab 29-1mg Primacare cap Provida OB cap R-natal OB cap 20-1-320 Redichew Rx chew Relnate DHA cap Se-Natal 19 tab Se-Natal 19 chew Select-OB chew Select-OB+DHA pak Taron-C DHA cap Taron-Prex cap Thrivite Rx tab 29-1mg TriCare prenatal Trinatal Rx tab 1 Tri-Tabs DHA mis TriStart DHA TriStart Free cap TriStart One cap 35-1-215 Triveen-duo pak DHA Vinate One tab Vinate II tab Vinate DHA cap 27-1.13 Vitatrue mis Virt-Nate cap DHA Virt-PN Plus cap Vitafol chew gummies Vitafol FE+cap Vitafol-Nano Vitafol-Nano tab Vitafol-OB Vitafol-OB pak +DHA Vitafol-One cap Vitafol Ultra vitaMedMD One Rx Vitapearl Vitathely Virt-C DHA cap Virt-PN DHA cap Viva DHA cap Vol-Plus Vol-Tab Rx tab VP-PNV-DHA cap Wescap-C DHA cap Wescap-PN DHA cap Wesnate DHA cap Westab Plus tab 27-1mg Westgel DHA cap Zalvit tab 13-1mg Zatean-PN DHA cap Zatean-PN Plus cap Ziphex |
Elite OB tab Inatal GT tab Prenatabs Rx tab Prenatal 19 chew tab PNV-DHA cap PNV-Select tab Trinate tab |
Medications with New Quality Care Dosing (QCD) Limit
To make sure that the quantity and dose of a medication meet the Food and Drug Administration, manufacturer, and clinical recommendations, the medication listed below now requires Quality Care Dosing (QCD).
Medication Class | Medication Name | New Coverage Limit |
---|---|---|
Tetracycline Antibiotic | Nuzyra 150 mg Tablet ONLY | 30 tablets per 30 days |
Medications Switching Tiers
When the cost of a medication changes, we may move the medication to a different tier. The medications listed below are moving to a lower tier under certain pharmacy plans, and what you pay for the following medications may decrease.
Medication Class | Medication Name | 2023 Tier for members with a three-tier pharmacy benefit | 2023 Tier for members with a four-tier pharmacy benefit | 2023 Tier for members with a five-tier pharmacy benefit | 2023 Tier for members with a six-tier pharmacy benefit |
---|---|---|---|---|---|
Monoclonal Antibodies | Nucala2 | Tier 2a | Tier 3b | Tier 4c | Tier 5d |
Xolair2 | Tier 2a | Tier 3b | Tier 4c | Tier 5d |
2. This medication also has prior authorization and/or step therapy requirements.
a. This medication was previously covered at Tier 3.
b. This medication was previously covered at Tier 4.
c. This medication was previously covered at Tier 5.
d. This medication was previously covered at Tier 6.
Coverage Changes for Certain Medications Moving from Our Medical to Pharmacy Benefit
Effective July 1, 2023, coverage for the following specialty medications will move out of our medical benefit and only be included under our pharmacy benefit. These medications will also only be covered when filled at an in-network specialty pharmacy. This change will apply to all medical plans, except Medicare Advantage, Medical Supplemental plans, and Federal Employee Program plans.
- Ilumya
- Skyrizi
If you’re currently filling these specialty medications at an in-network specialty pharmacy under your pharmacy benefit, you won’t experience a break in coverage as these medications move from the medical benefit to the pharmacy benefit. If you’re currently filling these medications under your medical benefit and have pharmacy coverage with Blue Cross Blue Shield of Massachusetts, you’ll receive a detailed letter about the coverage change, along with next steps. If you don’t have pharmacy coverage from Blue Cross Blue Shield of Massachusetts, we’ll also send you a letter about the change, with additional information about contacting your prescription plan to find out if you’re covered for these medications.
Medical Policy Updates
Blue Cross medical policies are developed by using evidence-based information to define the technologies, procedures, and treatments that are considered medically necessary, or not medically necessary, or investigational. We use pharmacy medical policies to describe how we cover certain medications. The policies listed below are being updated. Changes include:
- Step therapy policy changes that apply when the medication within the pharmacy medical policy is newly prescribed for members. With step therapy, you may need to try a less expensive (lower step) medication before we’ll cover a more expensive (higher step) medication. Your doctor can request an exception if needed.
- Prior authorization requirements for specific medications to ensure your doctor has determined that a medication is necessary to treat you, based on specific medical standards.
For this policy | Update |
---|---|
Immune Modulating Drugs Policy (004) | This policy will be updated to reflect the medical to pharmacy benefit coverage change for Ilumya and Skyrizi as noted below in the Injectable Specialty Medication Coverage Policy (071). |
Immunomodulators for Skin Conditions Policy (010) | Rinvoq coverage criteria will be updated to require the use of another systemic medication other than Dupixent, before it’s covered. The Drug-Systemic step table in this policy will be updated from a three-step to a two-step and will require the use of two Step 1 medications prior to a Step 2 medication being approved. As a result, Cibinqo will move from Step 3 to Step 2 with in this policy. This will apply to you if these medications are newly prescribed. |
Injectable Asthma Medications Policy (017) | A prescription by a specialist will no longer be required in order for Xolair to be covered. Prior authorization will be required for new prescriptions. |
Injectable Specialty Medication Coverage Policy (071) | Ilumya and Skyrizi will be added to this policy. These medications will be covered only under the pharmacy benefit starting July 1, 2023 and prior authorization will be required for new prescriptions. |
Medical Utilization Management (MED UM) & Pharmacy Prior Authorization Policy (033) | Step therapy requirements will be updated to require the use of a steroid and tacrolimus or pimecrolimus, before covering Dupixent (when used to treat atopic dermatitis, also known as eczema). |
Looking for More Information?
For more information about any of these medications, go to the Medication Lookup tool.
If you have any questions, call Team Blue at the Member Service number on the front of your ID card.
Quality Care Dosing Limits Have Increased for Select Medications
To give doctors greater flexibility when prescribing certain controlled substances, we’ve doubled the quality care dosing limit for the medications listed below. The change took effect on April 12, 2023, and applies to members whose plans have pharmacy coverage through Blue Cross Blue Shield of Massachusetts and use the Blue Cross formulary.
The following medications increased coverage to 60 units for a 30-day supply:
- AMPHETAMINE/DEXTROAMPHETAMINE CAP 5MG ER
- AMPHETAMINE/DEXTROAMPHETAMINE CAP 10MG ER
- AMPHETAMINE/DEXTROAMPHETAMINE CAP 15MG ER
- AMPHETAMINE/DEXTROAMPHETAMINE CAP 25MG ER
- METHYLPHENIDATE TAB 18MG ER
- METHYLPHENIDATE TAB 27MG ER
- METHYLPHENIDATE TAB 54MG ER
The following medications increased coverage to 120 units for a 30-day supply:
- AMPHETAMINE/DEXTROAMPHETAMINE CAP 20MG ER
- AMPHETAMINE/DEXTROAMPHETAMINE CAP 30MG ER
- METHYLPHENIDATE TAB 36MG ER
If you have any questions, call Team Blue at the Member Service number on the front of your ID card.
Effective July 1, 2023, Upcoming Changes to the Blue Cross Blue Shield of Massachusetts Formulary and Medical Policy Updates
Effective July 1, 2023, we’re updating our formulary (list of covered medications) for medical plans with pharmacy benefits, as well as Medex®´* plans with a three-tier pharmacy benefit. As part of this update, certain medications may:
- No longer be covered (exceptions may be granted)
- Be excluded from coverage (exceptions won’t be granted)
- Switch tiers
- Require prior authorization and/or step therapy
- No longer be covered under the medical benefit and will only be covered under the pharmacy benefit
We’re also making medical policy changes, effective July 1, 2023.
Complete details about these changes will be available by May 31, 2023. Check back at that time.
Questions?
If you have any questions, call Team Blue at the Member Service number on the front of your ID card.
*This doesn’t include Medex®´ 2 plans with Blue MedicareRx (PDP) prescription drug coverage.
Effective January 1, 2023, Upcoming Changes to the Blue Cross Blue Shield of Massachusetts Formulary
Effective January 1, 2023, we’re updating our formulary (list of covered medications) for medical plans with pharmacy benefits, as well as Medex®´* plans with a three-tier pharmacy benefit. As part of this update, certain medications may:
- No longer be covered (exceptions may be granted)
- Be excluded from coverage (exceptions won’t be granted)
- Switch tiers
- Require prior authorization and/or step therapy
*This doesn’t include Medex®´ 2 plans with Blue MedicareRx (PDP) prescription drug coverage.
Medications No Longer Covered Starting January 1, 2023
After carefully reviewing each medication’s cost and its clinically appropriate covered alternatives, we’ve removed the medications listed below from our formulary. However, a doctor may request an exception if the medication prescribed is medically necessary. If the exception is approved, you’ll pay the highest-tier cost.
Medication Class | Medication Name | Covered Alternative |
---|---|---|
Antidiabetic — Dipeptidyl Peptidase-4 (DPP4) Enzyme Inhibitor and Combinations |
Kombiglyze XR1 Onglyza1 |
Glyxambi1 Janumet1 Janumet XR1 Januvia1 Trijardy XR1 |
Antidiabetic — Glucagon-like Peptide-1 (GLP1) Receptor Antagonists (injectable) |
Bydureon1 Bydureon BCise1 Byetta1 |
Ozempic1 Trulicity1 Victoza1 |
Inflammatory Conditions | Actemra1,2.3 Actemra ACTPen1,2,3 Cimzia1,2 Ilumya1,2 Kineret1,2 Olumiant1,2 Orencia1,2 Orencia ClickJect1,2 Siliq1,2 Simponi1,2 |
Enbrel1 Humira1 Kevzara1 Otezla1 Rinvoq ER1 Skyrizi1 Stelara1 Taltz1 Tremfya1 Xeljanz1 Xeljanz XR1 |
Migraine Treatment — Calcitonin Gene-Related Peptide (CGRP) |
Qulipta1,2 Vyepti1,2,3 |
Aimovig1 Ajovy1 Emgality1 Nurtec1 |
Multiple Sclerosis Treatment | Bafiertam1,2,3 | dimethyl fumarate |
- This medication also has prior authorization and/or step therapy requirements.
- If you currently use this medication, you’ll continue to be covered until your prior authorization expires.
- If you use this medication, you’ll experience a copay increase as of January 1, 2023.
Medications Excluded from Coverage
Certain medications will be excluded from our pharmacy benefit, effective January 1, 2023. You’ll be responsible for the full cost of these medications when filling a prescription at the pharmacy. This change will apply to all commercial plans, group Medex®´plans with pharmacy benefits, and Managed Blue for Seniors. Formulary exceptions won’t be accepted for these medications. We’ll contact you if you’ll be affected by this change.
To find out if a medication is excluded from coverage, effective January 1, 2023, use the Medication Lookup tool.
Medications Switching Tiers
When the cost of a medication changes, we may move the medication to a different tier. The medications listed below are moving to a lower or higher tier under certain pharmacy plans, and what you pay for the following medications may increase or decrease. This isn’t a complete list of medications switching tiers, and we’ll contact you if you’ll be affected by this change.
To find out which tier a medication is in, effective January 1, 2023, use the Medication Lookup tool.
Medication Class | Medication Name | 2023 Tier for members with a three-tier pharmacy benefit | 2023 Tier for members with a four-tier pharmacy benefit | 2023 Tier for members with a five-tier pharmacy benefit | 2023 Tier for members with a six-tier pharmacy benefit |
---|---|---|---|---|---|
Antidiabetic – GLP1 Receptor Antagonists (injectable) | Ozempic* Victoza* |
Tier 2e | Tier 3e | Tier 2e | Tier 3e |
Antidiabetic – GLP1 Receptor Antagonist (oral) | Rybelsus* | Tier 2e | Tier 3e | Tier 2e | Tier 3e |
Antiobesity (injectable) | Contrave XR* Saxenda* |
Tier 2a | Tier 3b | Tier 2a | Tier 3b |
Irritable Bowel Syndrome Treatment (oral) | Xifaxan* | Tier 3e | Tier 4e | Tier 3e | Tier 4e |
Multiple Sclerosis Treatment | Aubagio* | Tier 2a | Tier 3b | Tier 4c | Tier 5d |
Vumerity* | Tier 2e | Tier 3e | Tier 4e | Tier 5e |
* This medication also has prior authorization and/or step therapy requirements.
- This medication was previously covered at Tier 3.
- This medication was previously covered at Tier 4.
- This medication was previously covered at Tier 5.
- This medication was previously covered at Tier 6.
- This medication was previously non-covered.
Medical Policy Updates
Blue Cross medical policies are developed by using evidence-based information to define the technologies, procedures, and treatments that are considered medically necessary, or not medically necessary, or investigational. We use pharmacy medical policies to describe how we cover certain medications. We’re updating the policies listed below. These changes include:
- Step therapy policy changes that apply when the medication within the pharmacy medical policies is newly prescribed for you. With step therapy, you may need to try a less expensive (lower step) medication before we’ll cover a more expensive (higher step) medication. Your doctor can request an exception if needed.
- Prior authorization requirements for specific medications to ensure your doctor has determined that a medication is necessary to treat you, based on specific medical standards.
For this policy | Update |
---|---|
Anti-Migraine Policy (021) | Qulipta and Vyepti are moving from covered to non-covered. Prior authorization requirements will still apply. If you currently use these medications, you’ll continue to be covered until your prior authorization expires. The prescription lookback period for step therapy is changing for the following medications: Aimovig, Ajovy, and Emgality. This applies to you if these medications have been newly prescribed. |
Diabetes Step Therapy (041) | Bydureon, Bydureon BCise, Byetta, Kombiglyze XR, and Onglyza are moving from covered to non-covered. As a result, these medications will move from Step 2 to Step 3 within this policy. If you currently use these medications, or if they’re newly prescribed, new prior authorization is required. Ozempic, Rybelsus, and Victoza are moving from non-covered to covered. As a result, these medications will move from Step 3 to Step 2 within this policy. |
Immune Modulating Medications (004) | All medications in this policy will move from indication-based prior authorization to non-indication-based prior authorization. Preferred medications must be used before non-preferred medications will be approved and covered. Actemra, Actemra ACTPen, Cimzia, Ilumya, Kineret, Olumiant, Orencia, Orencia ClickJect, Siliq, and Simponi are moving from covered to non-covered. If you currently use these medications, you’ll continue to be covered until your prior authorization expires. Some members currently using these medications will experience an increase in out-of-pocket costs. If these medications are newly prescribed for you, prior authorization is required. |
Drug Management and Retail Pharmacy Prior Authorization Policy (049) | Xifaxan will move from non-covered to covered. Prior authorization requirements will be required to check against Food and Drug Administration requirements. If you currently use these medications, you’ll continue to be covered until your prior authorization expires. |
Multiple Sclerosis Step Therapy (839) | Prior authorization will be required for the following medications, to check against Food and Drug Administration requirements: Aubagio, Gilenya, Mavenclad, Mayzent, Vumerity, and Zeposia. |
Looking for More Information?
For more information about any of these medications, use the Medication Lookup tool.
Questions?
If you have any questions, call Team Blue at the Member Service number on the front of your ID card.
Effective January 1, 2023, Upcoming Changes to the Blue Cross Blue Shield of Massachusetts Formulary
Effective January 1, 2023, we’re updating our formulary (list of covered medications) for medical plans with pharmacy benefits, as well as Medex®´* plans with a three-tier pharmacy benefit. As part of this update, certain medications may:
- No longer be covered (exceptions may be granted)
- Be excluded from coverage (exceptions won’t be granted)
- Switch tiers
- Require prior authorization and/or step therapy
*This doesn’t include Medex®´ 2 plans with Blue MedicareRx (PDP) prescription drug coverage.
Medications No Longer Covered Starting January 1, 2023
After carefully reviewing each medication’s cost and its clinically appropriate covered alternatives, we’ve removed the medications listed below from our formulary. However, a doctor may request an exception if the medication prescribed is medically necessary. If the exception is approved, you’ll pay the highest-tier cost.
Medication Class | Medication Name | Covered Alternative |
---|---|---|
Antidiabetic — Dipeptidyl Peptidase-4 (DPP4) Enzyme Inhibitor and Combinations |
Kombiglyze XR1 Onglyza1 |
Glyxambi1 Janumet1 Janumet XR1 Januvia1 Trijardy XR1 |
Antidiabetic — Glucagon-like Peptide-1 (GLP1) Receptor Antagonists (injectable) |
Bydureon1 Bydureon BCise1 Byetta1 |
Ozempic1 Trulicity1 Victoza1 |
Inflammatory Conditions | Actemra1,2.3 Actemra ACTPen1,2,3 Cimzia1,2 Ilumya1,2 Kineret1,2 Olumiant1,2 Orencia1,2 Orencia ClickJect1,2 Siliq1,2 Simponi1,2 |
Enbrel1 Humira1 Kevzara1 Otezla1 Rinvoq ER1 Skyrizi1 Stelara1 Taltz1 Tremfya1 Xeljanz1 Xeljanz XR1 |
Migraine Treatment — Calcitonin Gene-Related Peptide (CGRP) |
Qulipta1,2 Vyepti1,2,3 |
Aimovig1 Ajovy1 Emgality1 Nurtec1 |
Multiple Sclerosis Treatment | Bafiertam1,2,3 | dimethyl fumarate |
- This medication also has prior authorization and/or step therapy requirements.
- If you currently use this medication, you’ll continue to be covered until your prior authorization expires.
- If you use this medication, you’ll experience a copay increase as of January 1, 2023.
Medications Excluded from Coverage
Certain medications will be excluded from our pharmacy benefit, effective January 1, 2023. You’ll be responsible for the full cost of these medications when filling a prescription at the pharmacy. This change will apply to all commercial plans, group Medex®´plans with pharmacy benefits, and Managed Blue for Seniors. Formulary exceptions won’t be accepted for these medications. We’ll contact you if you’ll be affected by this change.
To find out if a medication is excluded from coverage, effective January 1, 2023, use the Medication Lookup tool.
Medications Switching Tiers
When the cost of a medication changes, we may move the medication to a different tier. The medications listed below are moving to a lower or higher tier under certain pharmacy plans, and what you pay for the following medications may increase or decrease. This isn’t a complete list of medications switching tiers, and we’ll contact you if you’ll be affected by this change.
To find out which tier a medication is in, effective January 1, 2023, use the Medication Lookup tool.
Medication Class | Medication Name | 2023 Tier for members with a three-tier pharmacy benefit | 2023 Tier for members with a four-tier pharmacy benefit | 2023 Tier for members with a five-tier pharmacy benefit | 2023 Tier for members with a six-tier pharmacy benefit |
---|---|---|---|---|---|
Antidiabetic – GLP1 Receptor Antagonists (injectable) | Ozempic* Victoza* |
Tier 2e | Tier 3e | Tier 2e | Tier 3e |
Antidiabetic – GLP1 Receptor Antagonist (oral) | Rybelsus* | Tier 2e | Tier 3e | Tier 2e | Tier 3e |
Antiobesity (injectable) | Contrave XR* Saxenda* |
Tier 2a | Tier 3b | Tier 2a | Tier 3b |
Irritable Bowel Syndrome Treatment (oral) | Xifaxan* | Tier 3e | Tier 4e | Tier 3e | Tier 4e |
Multiple Sclerosis Treatment | Aubagio* | Tier 2a | Tier 3b | Tier 4c | Tier 5d |
Vumerity* | Tier 2e | Tier 3e | Tier 4e | Tier 5e |
* This medication also has prior authorization and/or step therapy requirements.
- This medication was previously covered at Tier 3.
- This medication was previously covered at Tier 4.
- This medication was previously covered at Tier 5.
- This medication was previously covered at Tier 6.
- This medication was previously non-covered.
Medical Policy Updates
Blue Cross medical policies are developed by using evidence-based information to define the technologies, procedures, and treatments that are considered medically necessary, or not medically necessary, or investigational. We use pharmacy medical policies to describe how we cover certain medications. We’re updating the policies listed below. These changes include:
- Step therapy policy changes that apply when the medication within the pharmacy medical policies is newly prescribed for you. With step therapy, you may need to try a less expensive (lower step) medication before we’ll cover a more expensive (higher step) medication. Your doctor can request an exception if needed.
- Prior authorization requirements for specific medications to ensure your doctor has determined that a medication is necessary to treat you, based on specific medical standards.
For this policy | Update |
---|---|
Anti-Migraine Policy (021) | Qulipta and Vyepti are moving from covered to non-covered. Prior authorization requirements will still apply. If you currently use these medications, you’ll continue to be covered until your prior authorization expires. The prescription lookback period for step therapy is changing for the following medications: Aimovig, Ajovy, and Emgality. This applies to you if these medications have been newly prescribed. |
Diabetes Step Therapy (041) | Bydureon, Bydureon BCise, Byetta, Kombiglyze XR, and Onglyza are moving from covered to non-covered. As a result, these medications will move from Step 2 to Step 3 within this policy. If you currently use these medications, or if they’re newly prescribed, new prior authorization is required. Ozempic, Rybelsus, and Victoza are moving from non-covered to covered. As a result, these medications will move from Step 3 to Step 2 within this policy. |
Immune Modulating Medications (004) | All medications in this policy will move from indication-based prior authorization to non-indication-based prior authorization. Preferred medications must be used before non-preferred medications will be approved and covered. Actemra, Actemra ACTPen, Cimzia, Ilumya, Kineret, Olumiant, Orencia, Orencia ClickJect, Siliq, and Simponi are moving from covered to non-covered. If you currently use these medications, you’ll continue to be covered until your prior authorization expires. Some members currently using these medications will experience an increase in out-of-pocket costs. If these medications are newly prescribed for you, prior authorization is required. |
Drug Management and Retail Pharmacy Prior Authorization Policy (049) | Xifaxan will move from non-covered to covered. Prior authorization requirements will be required to check against Food and Drug Administration requirements. If you currently use these medications, you’ll continue to be covered until your prior authorization expires. |
Multiple Sclerosis Step Therapy (839) | Prior authorization will be required for the following medications, to check against Food and Drug Administration requirements: Aubagio, Gilenya, Mavenclad, Mayzent, Vumerity, and Zeposia. |
Looking for More Information?
For more information about any of these medications, use the Medication Lookup tool.
Questions?
If you have any questions, call Team Blue at the Member Service number on the front of your ID card.
Encompass Fertility™ Has Joined Our Specialty Pharmacy Network for Fertility Medications
Effective July 19, 2022, Encompass Fertility has joined our specialty pharmacy network for fertility medications. They have access to all our covered fertility medications, and they can fill and ship medications in all 50 states.
This change applies to plans with the Blue Cross Blue Shield of Massachusetts formulary, and the National Preferred Formulary (NPF). For more information about specialty fertility medications, use our Medication Lookup tool.
Questions?
If you have any questions, call Team Blue at the Member Service number on the front of your ID card.
Metro Drugs Is Leaving Our Specialty Pharmacy Network for Fertility Medications
Effective May 1, 2022, Metro Drugs, a fertility medication pharmacy, will be leaving our specialty pharmacy network. If you’re taking fertility medications and fill your prescriptions through Metro Drugs, you’ll be able to complete your current course of treatment with Metro Drugs, but treatments starting after May 1, 2022 will need to be filled through Freedom Fertility Pharmacy, or Village Fertility Pharmacy in order to be covered. If you’re currently using Metro Drugs, you’ll receive a letter from us about next steps.
This change applies to plans with the Blue Cross Blue Shield of Massachusetts formulary, and the National Preferred Formulary (NPF). For more information about specialty fertility medications, use our Medication Lookup tool.
Questions?
If you have any questions, call Team Blue at the Member Service number on the front of your ID card.
Upcoming Changes to the Blue Cross Blue Shield of Massachusetts Formulary and Pharmacy Medical Policy Updates
Effective July 1, 2022, we’re updating the Blue Cross Blue Shield of Massachusetts formulary (list of covered medications) for medical plans with pharmacy benefits, as well as Medex®´ plans with a three-tier pharmacy benefit.* As part of the formulary update, certain medications are switching tiers.
We’ve also discontinued a medical policy as of March 1, 2022, and we’re making additional medical policy changes on April 1, 2022 and July 1, 2022.
*This doesn’t include Medex 2 plans with Blue MedicareRx (PDP) prescription drug coverage.
Medications Switching Tiers
When the cost of a medication changes, we may move the medication to a different tier. The medications listed below are moving to a lower or higher tier under certain pharmacy plans, and what you pay for the following medications may increase or decrease.
Medication Class | Medication Name | 2022 Tier for members with a three-tier pharmacy benefit | 2022 Tier for members with a four-tier pharmacy benefit | 2022 Tier for members with a five-tier pharmacy benefit | 2022 Tier for members with a six-tier pharmacy benefit |
---|---|---|---|---|---|
Inflammatory Conditions | Avsola | Tier 2a | Tier 3b | Tier 4c | Tier 5d |
Neulasta | Tier 2a | Tier 3b | Tier 4c | Tier 5d | |
Ziextenzo | Tier 2a | Tier 3b | Tier 4c | Tier 5d |
- This medication was previously covered at Tier 3.
- This medication was previously covered at Tier 4.
- This medication was previously covered at Tier 5.
- This medication was previously covered at Tier 6.
Pharmacy Medical Policy Updates
Pharmacy medical policies are evidence-based documents that we develop to define the technologies, procedures, and treatments that are considered medically necessary; not medically necessary; and investigational. We use pharmacy medical policies to describe how we cover certain medications. We’re updating the following policies:
Policies | Update | Date of Change |
---|---|---|
Dificid (fidaxomicin) (700) | This step therapy policy has been discontinued. We no longer require members to have prior treatment or failure with vancomycin before covering Dificid (fidaxomicin). Members who have an approved exception to cover Dificid (fidaxomicin) don’t need their doctors to renew this request. |
3/1/2022 |
Immune Modulating Drugs (004) | Avsola will move from non-preferred to preferred within the Remicade and infliximab biosimilars policy section. Inflectra and Avsola will now be the preferred medications in this policy. |
4/1/2022 |
Quality Care Cancer Program (Medical Oncology) (099) Nononcologic Uses of Rituximab (123) |
Riabni will move from non-preferred to preferred. Truxima will move from preferred to non-preferred. Ruxience and Riabni will now be the preferred medications in these policies. Members currently using Truxima will have continued coverage so their care isn’t disrupted. |
7/1/2022 |
Quality Care Cancer Program (Medical Oncology) (099) | Herzuma, Ogivri, and Ontruzant will move from preferred to non-preferred. Kanjinti and Trazimera continue to be the preferred medications in this policy. Members currently using Herzuma, Ogivri, or Ontruzant will have continued coverage so their care isn’t disrupted. Providers who request prior authorization for Herzuma, Ogivri, and Ontruzant will need to go through AIM Specialty Health. |
7/1/2022 |
Medical Utilization Management (MED UM) & Pharmacy Prior Authorization Policy (033) Supportive Care Treatments for Patients with Cancer (105) |
Udenyca will move from preferred to non-preferred. Neulasta and Ziextenzo will move from non-preferred to preferred. Fulphila, Neulasta, and Ziextenzo will now be the preferred medications listed in these policies. Members currently using Udenyca will have continued coverage so their care isn’t disrupted. |
7/1/2022 |
Learn More About Medications
Use the Medication Lookup tool to learn more about coverage for these medications.
Questions?
If you have any questions, call Team Blue at the Member Service number on the front of your ID card.
Upcoming Changes to the Blue Cross Blue Shield of Massachusetts Formulary, Effective January 1, 2022
Beginning January 1, 2022, we’re updating our formulary (list of covered medications) for medical plans with pharmacy benefits, as well as Medex®´ * plans with a three-tier pharmacy benefit. As part of this update, certain medications may:
- No longer be covered (exceptions may be granted)
- Switch tiers
- Have new quantity or dosing limits
- Require prior authorization and/or step therapy
*This doesn’t include Medex 2 plans with Blue MedicareRx (PDP) prescription drug coverage.
Medications No Longer Covered Starting January 1, 2022
After carefully reviewing each medication’s cost and its clinically appropriate covered alternatives, we’ve removed the medications listed below from our formulary. However, a doctor may request an exception if the medication prescribed is medically necessary. If the exception is approved, you'll pay the highest-tier cost.
Medication Class | Medication Name | Covered Alternative |
---|---|---|
Anti-Parasite Treatment | Alinia | nitazoxanide |
Glaucoma Treatment | Timoptic Ocudose | betaxolol levobunolol metipranolol timolol |
H. Pylori Treatment | Omeclamox | lansoprazole/amoxicillin/ clarithromycin pack Talicia |
Multiple Sclerosis Treatment | Tecfidera* | dimethyl fumarate |
Musculoskeletal Pain Treatment | Norgesic Forte orphenadrine/aspirin/caffeine |
orphenadrine |
Nerve Pain Treatment | Lyrica | pregabalin* |
Phenylketonuria Treatment | Kuvan | sapropterin |
Short Acting Bronchodilators | ProAir HFA ProAir RespiClick |
albuterol sulfate HFA |
Topical Corticosteroids | triamcinolone 0.05% ointment Trianex 0.05% ointment Tritocin 0.05% ointment |
triamcinolone 0.025% cream, lotion, ointment triamcinolone 0.1% cream, lotion, ointment triamcinolone 0.5% cream, ointment |
*This medication also has prior authorization and/or step therapy requirements.
Medications Switching Tiers
When the cost of a medication changes, we may move the medication to a different tier. The medications listed below are moving to a lower or higher tier under certain pharmacy plans, and what you pay for the following medications may increase or decrease.
Medication Class | Medication Name | 2022 Tier for members with a three-tier pharmacy benefit | 2022 Tier for members with a four-tier pharmacy benefit | 2022 Tier for members with a five-tier pharmacy benefit | 2022 Tier for members with a six-tier pharmacy benefit |
---|---|---|---|---|---|
Inflammatory Conditions | Avsola* | Tier 3b | Tier 4c | Tier 5d | Tier 6e |
Cimzia* | Tier 3g | Tier 4g | Tier 5g | Tier 6g | |
Orencia* | Tier 3g | Tier 4g | Tier 5g | Tier 6g | |
Orencia Clickjet* | Tier 3g | Tier 4g | Tier 5g | Tier 6g | |
Siliq* | Tier 3g | Tier 4g | Tier 5g | Tier 6g | |
Simponi* | Tier 3g | Tier 4g | Tier 5g | Tier 6g | |
Simponi Aria* | Tier 3g | Tier 4g | Tier 5g | Tier 6g | |
Bowel Evacuants | Plenvu | Tier 3g | Tier 4g | Tier 3g | Tier 4g |
Diabetes – SGLT2/DPP4 Inhibitor Combinations | Trijardy XR* | Tier 2c | Tier 3d | Tier 2c | Tier 3d |
Inhaled Combination Agents | Breztri* Trelegy Ellipta* |
Tier 2g | Tier 3g | Tier 2g | Tier 3g |
Methotrexate Autoinjectors | Otrexup* | Tier 3g | Tier 4g | Tier 5g | Tier 6g |
Methotrexate Autoinjectors | Rasuvo* | Tier 3g | Tier 4g | Tier 3g | Tier 4g |
*This medication also has prior authorization and/or step therapy requirements.
- This medication was previously covered at Tier 1.
- This medication was previously covered at Tier 2.
- This medication was previously covered at Tier 3.
- This medication was previously covered at Tier 4.
- This medication was previously covered at Tier 5.
- This medication was previously covered at Tier 6.
- This medication was previously non-covered.
Medications with New Quality Care Dosing Limits
To make sure that the quantity and dose of a medication meet the Food and Drug Administration, manufacturer, and clinical recommendations, some of the medications listed below now require Quality Care Dosing (QCD), while the QCD limit has changed for others.
Medication Class | Medication Name | Quality Care Dosing Limit per prescription |
---|---|---|
Anti-Parasite Treatment | Alinia 500 mg tablets Nitazoxanide 500 mg tablets |
6 tablets |
Alinia 100 mg/5 mL suspension | 180 mL | |
Antineoplastic Medications | Jakafi 5 mg, 10 mg, 15 mg, 20 mg, 25 mg tablets | 60 |
Pomalyst 1 mg, 2 mg, 3 mg, 4 mg capsules | 21 | |
Cabometyx 20 mg, 40 mg, 60 mg tablets | 30 | |
Tagrisso 40 mg, 80 mg tablets | 30 | |
Verzenio 50 mg, 100 mg, 150 mg, 200 mg tablets | 60 | |
Tardive Dyskinesia Treatment | Ingrezza 40 mg-80 mg initiation pack | 1 pack |
Ingrezza 40 mg, 60 mg, 80 mg capsules | 30 |
Medical Policy Updates
Medical policies are evidence-based documents that Blue Cross develops to define the technologies, procedures, and treatments that are considered medically necessary, not medically necessary, and investigational. We use Pharmacy medical policies to describe how we cover certain medications. We’re updating the policies listed below. These changes include:
- Step therapy policy changes that apply when the medication within the pharmacy medical policies is newly prescribed for you. With step therapy, you may need to try a less expensive (lower step) medication before we’ll cover a more expensive (higher step) medication. Your doctor can request an exception if needed.
- Prior authorization. This applies if you are newly prescribed Alunbrig.
For this policy | Update |
---|---|
Anti-Migraine Policy (021) | Adding dihydroergotamine spray and Migranal spray to step 3 for acute migraine treatment. This will apply to members newly prescribed these medications. |
Asthma and Chronic Obstructive Pulmonary Disease Medication Management (011) | Adding Trelegy Ellipta and Breztri as step 2 agents requiring the use of other covered products for Asthma/Chronic Obstructive Pulmonary Disease (COPD) to be used prior to approval. This will apply to members newly prescribed these medications. |
Diabetes Step Therapy (041) | Moving Trijardy XR from step 3 to step 2 under the DPP4 and SGLT2 sections of the policy. Members with a claim history or an approved authorization don’t need to do anything, but these medications will now be covered at a lower-tier cost. New prescriptions for this medication will follow the step therapy policy. |
Immune Modulating Drugs (004) | Adding Zeposia to non-preferred and requiring the use of two preferred agents prior to approval (when used to treat ulcerative colitis [UC]). This will apply to members newly prescribed these medications. |
Injectable Methotrexate (Otrexup & Rasuvo) (840) |
New medical policy that requires the use of generic methotrexate before we’ll approve coverage of either Otrexup or Rasuvo. Applies to new prescriptions. |
Multiple Sclerosis Step Therapy (839) | New medical policy that requires the use of dimethyl fumarate or glatiramer/Glatopa before we’ll cover other agents. Applies to new prescriptions. |
Oncology Drugs (409) | Requiring prior authorization for Alunbrig. Applies to new prescriptions. |
Looking for More Information?
For more information about any of these medications, use the Medication Lookup tool at bluecrossma.org/medication.
Questions?
If you have any questions, please call Member Service at the number on the front of your ID card.
Effective July 1, 2021, Upcoming Changes to the Blue Cross Blue Shield of Massachusetts Formulary
Beginning July 1, 2021, we’re updating our formulary (list of covered medications) for medical plans with pharmacy benefits, as well as Medex®´ plans* with a three-tier pharmacy benefit. As part of this update, certain medications may:
- No longer be covered (exceptions may be granted)
- Have new quantity or dosing limits
- Require prior authorization
*This doesn’t include Medex 2 plans with Blue MedicareRx (PDP) prescription drug coverage.
Medications No Longer Covered Starting July 1, 2021
After carefully reviewing each medication’s cost and its clinically appropriate covered alternatives, we’ve removed the medications listed below from our formulary. However, a doctor may request an exception if these medications are medically necessary. If the exception is approved, you’ll pay the highest-tier cost.
Medication Class | Medication Name | Covered Alternative | |
---|---|---|---|
Migraine Treatment | Allzital 25 mg/325 mg tablets | Butalbital/Acetaminophen 25 mg/325 mg tablets | |
Narcotic Analgesics** | Oxycodone ER Oxycontin 10 mg tablets Oxycontin 15 mg tablets Oxycontin 20 mg tablets Oxycontin 30 mg tablets Oxycontin 40 mg tablets Oxycontin 60 mg tablets Oxycontin 80 mg tablets |
Xtampza ER 9 mg capsules Xtampza ER 13.5 mg capsules Xtampza ER 18 mg capsules Xtampza ER 27 mg capsules Xtampza ER 36 mg capsules |
|
Prenatal Vitamin | Azeschew tablets | Mynatal Mynatal Advance Mynatal Plus Prenatabs FA Prenatabs Rx Trinate |
|
Tetracycline Antibiotic | Minocycline 50 mg tablets Minocycline 75 mg tablets Minocycline 100 mg tablets |
Minocycline 50 mg capsules Minocycline 75 mg capsules Minocycline 100 mg capsules |
**The covered alternatives for Narcotic Analgesics will be added to our formulary on April 1, 2021.
Medications with New Quality Care Dosing Limits
To make sure that the quantity and dose of a medication meet the Food and Drug Administration, manufacturer, and clinical recommendations, some of the medications listed below now require Quality Care Dosing (QCD), while the QCD limit has changed for others.
Medication Class | Medication Name | Quality Care Dosing Limit per prescription | ||
---|---|---|---|---|
Topical Antibiotic | Gentamicin 0.1% cream | 30 grams | ||
Gentamicin 0.1% ointment | 30 grams | |||
Topical Antibiotic/Corticosteroid Combination | Iodoquinol/Hydrocortisone/Aloe gel | 48 grams | ||
Topical Antifungal | Ciclopirox 0.77% cream | 90 grams | ||
Ciclopirox 0.77% gel | 100 grams | |||
Ciclopirox 1% shampoo | 120 mL | |||
Ciclopirox 0.77% topical suspension | 90 mL | |||
Nystatin, Nyamyc, Nystop 100,000 units/gram powder | 60 grams | |||
Topical Antiviral | Denavir 1% cream | 10 grams | ||
Topical Corticosteroids | Halobetasol propionate 0.05% cream | 50 grams | ||
Halobetasol propionate 0.05% ointment | 50 grams | |||
Topical Immunosuppresive | Pimecrolimus 1% cream | 120 grams |
Medications Requiring Prior Authorization
For certain medications, your doctor must first obtain approval before we cover them. The following medications now require prior authorization:
Medication Class | ||
---|---|---|
Fulphila | Granix | Nivestym |
Riabni | Ruxience | Truxima |
Udenyca | Zarxio | Ziextenzo |
Looking for More Information?
For more information about any of these medications, use the Medication Lookup tool.
Questions?
If you have any questions, call Team Blue at the Member Service number on your ID card.
Effective July 1, 2021, New Opioid Safety Review to Be Implemented at Pharmacies
Effective July 1, 2021, pharmacists filling an opioid prescription will be alerted if you may be receiving a total level of opioids that’s potentially unsafe. This change applies to plans with the Blue Cross Blue Shield of Massachusetts formulary, as well as Medex®’ plans* with a three-tier pharmacy benefit and Managed Blue for Seniors plans.
Under this safety review, when a pharmacist is filling an opioid prescription, they’ll receive a real-time alert if your total opioid dose across all opioid or opioid-containing prescriptions reaches or exceeds 90 morphine milligram equivalents (MME) per day. If the pharmacist determines the opioid dose is appropriate for care, they can fill the prescription. However, if they believe there could be a safety issue, they may choose not to fill the prescription.
If the pharmacist doesn’t fill the prescription, your prescribing doctor can contact Blue Cross to request authorization for coverage. If authorized, coverage will be approved for up to one year. However, one of the following must be true for the request to be approved:
- The member has a diagnosis of cancer.
- The member is receiving opioids as part of palliative care.
- The prescriber says that the amount of opioid prescribed is necessary for adequate pain management, based on the member’s clinical circumstances.
This safety review doesn’t apply to prescriptions written by in-network oncologists, palliative care providers, and pain management specialists.
Questions?
If you have any questions, call Team Blue at the Member Service number on your ID card.
*This doesn’t include Medex 2 plans with Blue MedicareRx (PDP) prescription drug coverage.
Upcoming Coverage Changes for Certain Medications Moving from Our Medical to Pharmacy Benefit
Effective July 1, 2021, coverage for the following medications will move out of our medical benefit and only be included under our pharmacy benefit. This change will apply to all medical plans, except Managed Blue for Seniors, group Medicare Advantage, group Medex®´, and Federal Employee Program plans.
Medications Moving from Our Medical to Pharmacy Benefit | |||
---|---|---|---|
Available at Retail Pharmacies | Durolane* | Gel-One* | GelSyn-3* |
Monovisc* | Triluron* | Trivisc* | |
Must Be Filled at a Specialty Pharmacy | Bynfezia | Cosentyx* | Dupixent* |
Fasenra* | Kevzara* | Nucala* | |
Siliq* | Strensiq | Tegsedi* | |
Tremfya* |
Members who have plans with the Blue Cross Blue Shield of Massachusetts formulary, as well as Medex®’ plans** with a three-tier pharmacy benefit, or the National Preferred Formulary*** will receive coverage for these medications under their pharmacy benefit upon the effective date. Members with these plans will not experience a break in coverage as these medications move from the medical benefit to the pharmacy benefit. Group Medex plans with a three-tier pharmacy benefit will include coverage for these medications under both the medical and pharmacy benefit. If you don’t have pharmacy coverage from Blue Cross Blue Shield of Massachusetts, refer to your pharmacy plan benefit materials for coverage details on these medications.
If affected, we’ll contact you about this change and help you transition your prescription to support uninterrupted coverage.
This change doesn’t apply when these medications are administered in inpatient, surgical day care, ambulatory surgery center, and emergency department settings.
Questions?
For more information, call Team Blue at the Member Service number on your ID card.
*These medications require prior authorization.
**This doesn’t include Medex 2 plans with Blue MedicareRx (PDP) prescription drug coverage.
***Plans with the National Preferred Formulary may have additional coverage requirements for these medications.
Coverage for Certain Infused Oncology Medications Moving to the Medical Benefit
Effective July 1, 2021, the infused oncology medications listed below will only be covered under our medical benefit through the Quality Care Cancer Program and will require prior authorization. These medications will no longer be included in our pharmacy benefit.
Oncology Medications That Will Be Covered Under Our Medical Benefit | ||
---|---|---|
Abraxane | Herceptin | Onivyde |
Arzerra | Herceptin Hylecta | Ontruzant |
Bavencio | Herzuma | Opdivo |
Cyramza | Imfinzi | Poteligeo |
Doxil/Lipodox | Kanjinti | Proleukin |
Empliciti | Keytruda | Rituxan-Hycela |
Fusilev | Khapzory | Tecentriq |
Gazyva | Ogivri | Trazimera |
The Quality Care Cancer Program, which launches July 1, 2021, is administered by AIM Specialty Health®´´ (AIM), an independent company. You can learn more about this program, which helps ensure the cancer treatments we cover are safe and appropriate for our members, here.
This change only applies to plans with the Blue Cross Blue Shield of Massachusetts formulary, as well as Medex®´ plans* with a three-tier pharmacy benefit. This change doesn’t apply to group Medicare Advantage and Federal Employee Program plans. If you’re a member of an affected plan and are currently filling these medications under the pharmacy benefit, you’ll be able to complete your treatment course without interruption.
If your plan includes medical benefits from Blue Cross and pharmacy benefits from another carrier, you can receive coverage for these medications from us under your medical benefit. To see if you’re also covered by your pharmacy benefits from another carrier, please refer to your pharmacy plan benefit materials.
Questions?
If you have any questions, call Team Blue at the Member Service number on your ID card.
*This doesn’t include Medex 2 plans with Blue MedicareRx (PDP) prescription drug coverage.
Upcoming Changes to Opioid Coverage
We’re making several changes to our coverage of opioids, a class of medication that’s sometimes prescribed by doctors and providers to treat pain. Effective April 1, 2021, we’ll cover Xtampza ER. With this change, we’ll no longer cover OxyContin and Oxycodone ER, the authorized generic, as of July 1, 2021. We’ll work with prescribers to transition members to Xtampza ER, the covered alternative, when clinically appropriate. Prescribers will need to request prior authorization for Xtampza ER.
If a member needs to continue taking OxyContin or Oxycodone ER, their prescriber may request an exception if the medication is medically necessary. If the exception is approved, the member will pay the highest-tier cost.
Prescribers without Prior Authorization Must Request It before July 1, 2021
To support the safe and appropriate use of opioids, we’re expanding our Pain Management Policy. With the expansion, prescribers who don’t have an approved authorization for coverage of a member’s opioid medication must request authorization for that member’s medication before July 1, 2021. We’ll then review the request to determine if the medication is medically necessary. Prescribers who’ve already received prior authorization for a member’s opioid medication don’t need to request it again until it expires. Oncologists, palliative care providers, and pain management specialists in the Blue Cross Blue Shield of Massachusetts network are exempt from this prior authorization requirement. We’ll notify you and your prescriber if this change applies to you.
If you have any questions, please call Member Service on the front of your ID card.
Updates to the Blue Cross Blue Shield of Massachusetts Formulary Changes, Effective January 1, 2021
We previously announced changes to the Blue Cross Blue Shield of Massachusetts formulary (list of covered medications) that are going into effect January 1, 2021. Since then, we’ve made updates to these formulary changes. The updates are as follows:
Medications No Longer Covered Starting January 1, 2021
The non-covered and covered alternatives for high-triglyceride treatments and muscle relaxants are changing. Chlorzoxazone 250 mg will no longer be a covered alternative to specific Lorzone medications and will remain non-covered. The correct medications and covered alternatives are listed below:
Medication Class | Medication Name | Covered Alternatives |
---|---|---|
High-triglyceride treatments | fenofibrate 50 mg fenofibrate 150 mg |
fenofibrate 40 mg fenofibrate 43 mg fenofibrate 48 mg fenofibrate 54 mg fenofibrate 67 mg fenofibrate 120 mg fenofibrate 130 mg fenofibrate 134 mg fenofibrate 145 mg fenofibrate 160 mg fenofibrate 200 mg |
Muscle relaxants | cyclobenzaprine 7.5 mg | cyclobenzaprine 5 mg cyclobenzaprine 10 mg |
Lorzone 375 mg Lorzone 750 mg |
chlorzoxazone 500 mg |
Medications Switching Tiers
Medications in the high-triglyceride treatment class listed below will move to a higher cost tier, so what you pay for the following medications may increase.
Medication Class | Medication Name | 2021 Tier for members with a three-tier pharmacy benefit | 2021 Tier for members with a four-tier pharmacy benefit | 2021 Tier for members with a five-tier pharmacy benefit | 2021 Tier for members with a six-tier pharmacy benefit |
---|---|---|---|---|---|
High-triglyceride treatments | fenofibrate 40 mg, 43 mg, 120 mg, and 130 mg | Tier 2a | Tier 3b | Tier 2a | Tier 3b |
a. This medication was previously covered at Tier 1.
b. This medication was previously covered at Tier 2.
Medications with New Quality Care Dosing Limits
Quality Care Dosing helps us ensure that the quantity and dose of certain prescription medications meet the Food and Drug Administration, manufacturer, and clinical recommendations. Two additional medications will have Quality Care Dosing limits:
Medication Class | Medication Name | Quality Care Dosing Limit per Prescription |
---|---|---|
Immunomodulators | Humira CF Pen 40 mg/0.4 ml | 2 pens |
Kineret 100 mg/0.67 ml syringe | 30 syringes |
If you have any questions, please call Member Service at the number on the front of your ID card.
Upcoming Changes to the Blue Cross Blue Shield of Massachusetts Formulary, Effective January 1, 2021
Beginning January 1, 2021, we’re updating our formulary (list of covered medications) for medical plans with pharmacy benefits, as well as Medex®´* plans with a three-tier pharmacy benefit. As part of this update, certain medications may:
- No longer be covered (exceptions may be granted)
- Be excluded from coverage (exceptions won’t be granted)
- Switch tiers
- Have new quantity or dosing limits
- Require prior authorization and/or step therapy
*This doesn’t include Medex 2 plans with Blue MedicareRxTM (PDP) prescription drug coverage.
Medications No Longer Covered Starting January 1, 2021
After carefully reviewing each medication’s cost and its clinically appropriate covered alternatives, we’ve removed the medications listed below from our formulary. However, a doctor may request an exception if these medications are medically necessary. If the exception is approved, you’ll pay the highest-tier cost.
Medication Class | Medication Name | Covered Alternative |
---|---|---|
Antihistamines | Ryvent 6 mg | carbinoxamine 4 mg |
Antihypertensive Agents | Lotrel | amlodipine/ |
Tarka | trandolapril/ |
|
Biologic Agents | Cosentyx | Enbrel Humira Otezla Skyrizi Stelara Taltz Tremfya Xeljanz Xeljanz XR |
Buprenorphine/Naloxone Sublingual Products | Bunavail Suboxone Zubsolv |
buprenorphine/naxolone SL film buprenorphine/naxolone SL tablets |
Colchicine Products | Colcrys | colchicine tablets Mitigare |
Contraceptives | NuvaRing | etonogestrel/ethinyl estradiol vaginal ring1 |
Cough/Cold Agents | benzonatate 150 mg | benzonatate 100 mg benzonatate 200 mg |
Glaucoma Treatments | Alphagan P Azopt Betimol Betoptic S Timoptic |
betaxolol brimonidine dorzolamide dorzolamide/timolol timolol |
High Triglyceride Treatments | fenofibrate 50 mg fenofibrate 150 mg |
fenofibrate 40 mg fenofibrate 43 mg fenofibrate 48 mg fenofibrate 54 mg fenofibrate 67 mg fenofibrate 120 mg fenofibrate 130 mg fenofibrate 134 mg fenofibrate 145 mg fenofibrate 160 mg fenofibrate 200 mg |
Infertility Treatments | Chorionic Gonadotropin Pregnyl |
Novarel Ovidrel |
Laxatives | Kristalose 10GM packets | lactulose syrup |
Muscle Relaxants | cyclobenzaprine 7.5 mg | cyclobenzaprine 5 mg cyclobenzaprine 10 mg |
Lorzone 375 mg Lorzone 750 mg |
chlorzoxazone 500 mg | |
Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) | Arthrotec 75 mg | diclofenac/misoprostol |
ketoprofen 25 mg | ketoprofen 50 mg ketoprofen 75 mg ketoprofen ER 200 mg |
|
Nalfon 400 mg Nalfon 600 mg |
fenoprofen 600 mg tablets | |
naproxen sodium CR 375 mg naproxen sodium CR 500 mg |
naproxen 250 mg naproxen 375 mg naproxen 500 mg tablets naproxen sodium 275 mg tablets naproxen sodium 550 mg tablets |
|
Ophthalmic Anti-Inflammatory Products | Lotemax Lotemax SM |
fluorometholone loteprednol prednisolone |
Oral Antibiotics | doxycycline hyclate 50 mg tablets | doxycycline hyclate 20 mg tablets doxycycline hyclate 50 mg capsules doxycycline hyclate 100 mg tablets/capsules doxycycline hyclate 150 mg tablets |
Oral Diabetes Treatments | ActoPlus MET ActoPlus MET XR |
pioglitazone/metformin |
Overactive Bladder Agents | Vesicare | darifenacin ER oxybutynin oxybutynin ER solifenacin tolterodine tolterodine ER trospium trospium XR |
Parkinson’s Treatments | Stalevo | carbidopa/levodopa/entacapone |
Prenatal Vitamins | Azesco Trinaz |
generic prenatal vitamin options1 |
Topical Actinic Keratosis Treatments | Carac 0.50% Zyclara 2.50% Zyclara 3.75% |
fluororacil cream fluororacil solution imiquimod cream |
Ulcerative Colitis Treatments | Apriso 0.375 GM | mesalamine 0.375 GM |
1. These products are eligible for $0 copay with a prescription, under the Affordable Care Act.
Medications Excluded from Coverage
The following medications will be excluded from our pharmacy benefit as of January 1, 2021. You’ll be responsible for the full cost of these medications when filling a prescription at the pharmacy. This change will apply to all commercial plans, group Medex®´plans with pharmacy benefits, and Managed Blue for Seniors. Formulary exceptions won’t be accepted for these medications.
Medication Name |
---|
diclofenac 1% gel1 |
Niacor 500 mg2 |
niacin 500 mg IR2 |
Voltaren 1% gel1 |
1. This medication is available over-the-counter without a prescription.
2. Over-the-counter alternatives that don’t require a prescription are available for this medication.
Medications Switching Tiers
When the cost of a medication changes, we may move the medication to a different tier. The medications listed below are moving to a lower or higher tier under certain pharmacy plans, and what you pay for the following medications may increase or decrease.
Medication Class | Medication Name | 2021 Tier for members with a three-tier pharmacy benefit | 2021 Tier for members with a four-tier pharmacy benefit | 2021 Tier for members with a five-tier pharmacy benefit | 2021 Tier for members with a six-tier pharmacy benefit |
---|---|---|---|---|---|
Bone Marrow Stimulants | Ziextenzo | Tier 3a | Tier 4a | Tier 5a | Tier 6a |
High-Cost Generic Agents | amlodipine/benazepril | Tier 2b | Tier 3b | Tier 2b | Tier 3b |
carbidopa/levodopa/entacapone | Tier 2b | Tier 3b | Tier 2b | Tier 3b | |
diclofenac/misoprostol | Tier 2b | Tier 3b | Tier 2b | Tier 3b | |
dutasteride/tamsulosin | Tier 2b | Tier 3b | Tier 2b | Tier 3b | |
trandolapril/verapamil | Tier 2b | Tier 3b | Tier 2b | Tier 3b | |
High triglyceride treatments | fenofibrate 40 mg, 43 mg, 120 mg, and 130 mg | Tier 2b | Tier 3c | Tier 2b | Tier 3c |
Topical Antiviral Treatments | Acyclovir cream | Tier 2b | Tier 3b | Tier 2b | Tier 3b |
Acyclovir ointment | Tier 1c | Tier 1c | Tier 1c | Tier 1c |
a. This medication was previously covered at Tier 2 and requires step therapy.
b. This medication was previously covered at Tier 1.
c. This medication was previously covered at Tier 2.
Medications with New Quality Care Dosing Limits
To make sure that the quantity and dose of a medication meet the Food and Drug Administration, manufacturer, and clinical recommendations, some of the medications listed below now require Quality Care Dosing (QCD), while the QCD limit has changed for others.
Medication Class | Medication Name | Quality Care Dosing Limit per prescription |
---|---|---|
Immunomodulators | Actemra 162 mg/0.9 ml syringe | 4 syringes |
Actemra Actpen 162 mg/0.9 ml | 4 pens | |
Cimzia 200 mg vial kit | 6 vials | |
Cimzia 2x200 mg/ml syringe kit | 2 kits | |
Cimzia 2x200 mg/ml start kit | 6 syringes | |
Humira CF 10 mg/0.1 ml syringe | 2 syringes | |
Humira CF 20 mg/0.2 ml syringe | 2 syringes | |
Humira CF 40 mg/0.4 ml syringe | 2 syringes | |
Humira CF Pedi-Crohn’s 80-40 mg kit | 2 syringes | |
Humira CF Pedi-Crohn’s 80 mg/0.8 ml kit | 2 syringes | |
Humira CF Pen 40 mg/0.4 ml | 2 pens | |
Kineret 100 mg/0.67 ml syringe | 30 syringes | |
Olumiant 1 mg tablets | 30 tablets | |
Orencia 50 mg/0.4 ml syringe | 4 syringes | |
Orencia 87.5 mg/0.7 ml syringe | 4 syringes | |
Orencia ClickJect 125 mg/ml autoinjector | 4 autoinjectors | |
Orencia 250 mg vial | 4 vials | |
Otezla 28-day starter pack | 55 tablets (1 pack) | |
Rinvoq ER 15 mg tablets | 30 tablets | |
Stelara 45mg/0.5ml vial | 1 vial | |
Stelara 45 mg/0.5 ml syringe | 1 syringe | |
Stelara 90 mg/ml syringe | 1 syringe | |
Topical Antiviral Treatments | acyclovir cream Zovirax cream |
two tubes per prescription two tubes per prescription |
Topical Corticosteroids | calcipotriene/betamethasone dipropionate ointment |
120 GM |
calcipotriene/betamethasone dipropionate scalp solution |
120ml | |
diflorasone 0.05% cream diflorasone 0.05% ointment |
120 GM |
Medications Requiring Prior Authorization
For certain medications, your doctor must first obtain approval before we cover them. The following medication now requires prior authorization:
Medication Name |
---|
Ziextenzo1 |
- Members currently filling prescriptions for this medication may continue to do so without prior authorization.
Looking for More Information?
For more information about any of these medications, use the Medication Lookup tool.
Questions?
If you have any questions, please call Member Service at the number on the front of your ID card.
Effective October 1, 2020, Inflectra Is Now Preferred over Remicade for Members with Existing Prescriptions
Effective October 1, 2020, the immune-modulating medication Inflectra is now the preferred brand-name medication over Remicade. This affects members 18 years and older with existing prescriptions, and applies to prescriptions covered under the medical and pharmacy benefit.
If you’re currently taking Remicade, you should have received a letter from us with the details of this coverage change, encouraging you to talk to your doctor about switching to Inflectra before your prior authorization for Remicade expires. If your doctor determines Remicade is medically necessary, your doctor can request an exception for coverage. If the exception is approved, you'll pay the highest-tier cost when filling the medication under the pharmacy benefit. If filling the medication under the medical benefit, you'll pay your usual out-of-pocket costs.
Prior authorization is required for Inflectra and Remicade prescriptions.
Questions?
If you have any questions, call the Member Service number on the front of your ID card.
Sam’s Club Will Remain in Our Pharmacy Network
We’re pleased to announce that Sam’s Club will remain in our pharmacy network. You can continue to fill prescriptions at Sam’s Club pharmacy locations without interruption to your coverage.
If you recently filled a prescription at Sam’s Club, and received letters explaining that the pharmacy would be leaving the network, you can disregard these letters. New letters will be sent to you, confirming that the pharmacy will stay in-network.
Questions?
If you have any questions, please call Member Service at the number on your ID card.
Changes to Our Specialty Pharmacy Network for Fertility Medications
Beginning August 31, 2020, AcariaHealth™ Fertility will no longer participate in our specialty pharmacy network for fertility medications. This change applies to plans with the Blue Cross Blue Shield of Massachusetts formulary, and the National Preferred Formulary (NPF).
Members will be able to complete their current course of treatment with AcariaHealth Fertility; however, specialty fertility medications purchased through AcariaHealth Fertility after August 31, 2020, will no longer be covered. We’ll contact members who fill their prescriptions at AcariaHealth Fertility to let them know that the pharmacy is leaving our specialty fertility network, and help them transition to another in-network specialty pharmacy for fertility medications. This change only applies to AcariaHealth Fertility and our specialty fertility network. AcariaHealth Fertility’s parent company, AcariaHealth, will remain in our specialty pharmacy network.
Specialty pharmacies provide specialty medications that are used to treat certain complex health conditions. For more information about specialty medications, use our Medication Lookup tool.
If you have any questions, please call Member Service at the number on the front of your ID card.
Upcoming Changes to the Blue Cross Blue Shield of Massachusetts Formulary, Effective October 1, 2020
Effective October 1, 2020, we're updating our formulary (list of covered medications) for medical plans with pharmacy benefits, as well as Medex®´* plans with a three-tier pharmacy benefit. This update includes changes that were originally scheduled to go into effect on May 1 and July 1. As part of this update, certain medications may:
- No longer be covered (exceptions may be granted)
- Be excluded from coverage (exceptions won’t be granted)
- Switch tiers
- Have new quantity or dosing limits
- Require step therapy
*This doesn’t include Medex 2 plans with Blue MedicareRx™ (PDP) prescription drug coverage.
Medications No Longer Covered Starting October 1, 2020
After carefully reviewing each medication's cost and their clinically appropriate covered alternatives, we've removed the medications listed below from our list of covered medications. However, a doctor may request an exception if these medications are medically necessary. If the exception is approved, you’ll pay the highest-tier cost.
Medication Class | Medication Name | Covered Alternative |
---|---|---|
Acne (topical) | Differin 0.3% gel pump | Adapalene 0.3% gel |
Retin-A cream | Tretinoin cream | |
Acne (topical)/Psoriasis | Fabior 0.1% foam Tazorac 0.5% and 0.1% cream Tazorac 0.5% and 0.1% gel |
Tazarotene |
Analgesics (non-narcotic) | Tramadol ER capsules | Tramadol ER tablets |
Anticonvulsants | Depakote Depakote ER Depakote Sprinkle |
Divalproex Divalproex ER Divalproex Sprinkle |
Keppra | Levetiracetam Levetiracetam ER |
|
Lamictal Lamictal ODT Lamictal XR |
Lamotrigine Lamotrigine ODT Lamotrigine XR |
|
Topamax | Topiramate | |
Trileptal | Oxcarbazepine | |
Zonegran | Zonisamide | |
Antidepressants | Fluoxetine tablets Venlafaxine ER tablets |
Fluoxetine capsules Venlafaxine ER capsules |
Antidepressants/ Nerve Pain |
Savella | Duloxetine Pregabalin |
Antineoplastics | Arimidex | Anastrozole |
Aromasin | Exemestane | |
Gleevec | Imatinib | |
Aspirin Products | Duralaza | 81 mg aspirin1 Over-the-counter 325 mg aspirin2 |
Blood Pressure | Nitro-Dur 0.1 mg/hr patch Nitro-Dur 0.2 mg/hr patch Nitro-Dur 0.3 mg/hr patch Nitro-Dur 0.4 mg/hr patch Nitro-Dur 0.6 mg/hr patch Nitro-Dur 0.8 mg/hr patch |
Nitroglycerin patch |
Chemotherapy/ Protective Agent |
Fusilev | Levoleucovorin |
Diabetes | Invokamet Invokamet XR Invokana |
Farxiga Jardiance Synjardy Synjardy XR Xigduo XR |
Erectile Dysfunction (oral) | Cialis3 Levitra3 Staxyn3 Stendra3 Viagra3 |
Sildenafil4 |
Irritable Bowel Syndrome Treatment | Zelnorm | Amitiza Linzess Motegrity |
Migraine | Imitrex 6mg/0.5ml injection | Sumatriptan 6mg/0.5ml injection |
Multiple Sclerosis Treatment | Copaxone | Glatiramer Glatopa |
Ophthalmic Combinations | Tobradex Zylet |
Neomycin/Bacitracin/Polymyxin B/Hydrocortisone, Neomycin/Polymyxin B/Dexamethasone, Neomycin/Polymyxin B/Hydrocortisone, Sulfacetamide/Prednisolone, Tobramycin/Dexamethasone |
Smoking Cessation | Zyban 150 mg | Bupropion SA 150 mg |
Thrombocytopenia Treatment | Mulpleta | Doptelet |
1. This over-the-counter product is eligible for $0 copay with a prescription, under the Affordable Care Act.
2. This over-the-counter product is excluded from coverage. Exceptions won’t be accepted.
3. The quantity limit for this medication is 4 units per prescription, unless an exception is approved for more.
4. The quantity limit is increasing from 4 to 6 tablets per prescription on October 1, 2020.
Compounded Medications Excluded from Coverage
The following compounded medications will be excluded from our pharmacy benefit, effective October 1, 2020. If any of these medications is used as an ingredient in a compounded medication in the exact strength and form listed below, you may be responsible for the full cost of the medication. This change will apply to all medical plans, group Medex* plans with pharmacy benefits, and Managed Blue for Seniors with pharmacy benefits. Formulary exceptions won’t be accepted for these medications.
Medication Class | Medication Name | Strength and Form |
---|---|---|
Anticonvulsants | Carbamazepine | 100 mg chew tablet 200 mg tablet |
Antidepressants | Amitriptyline | 10 mg tablets 25 mg tablets 50 mg tablets 75 mg tablets 100 mg tablets 150 mg tablets |
Clomipramine | 25 mg capsules 50 mg capsules 75 mg capsules |
|
Imipramine Pamoate | 75 mg capsules 100 mg capsules 125 mg capsules 150 mg capsules |
|
Nitroglycerin | Nitro-Bid | 2% ointment |
Medications Switching Tiers
When the cost of a medication changes, we may move the medication to a different tier. The medications listed below are moving to a higher tier under certain pharmacy plans and may cost more.
Medication Class | Medication Name | 2020 Tier for members with a three-tier pharmacy benefit |
2020 Tier for members with a four-tier pharmacy benefit |
2020 Tier for members with a five-tier pharmacy benefit |
2020 Tier for members with a six-tier pharmacy benefit |
---|---|---|---|---|---|
Erectile Dysfunction (oral) | Tadalafil | Tier 3a | Tier 4b | Tier 3a | Tier 4b |
Erectile Dysfunction (oral) | Vardenafil | Tier 3a | Tier 4b | Tier 3a | Tier 4b |
a. This medication was previously covered at Tier 1.
b. This medication was previously covered at Tier 2.
Medications with New Quality Care Dosing Limits
To make sure that the quantity and dose of a medication meet the Food and Drug Administration, manufacturer, and clinical recommendations, some of the medications listed below now require Quality Care Dosing (QCD), while the QCD limit has changed for others.
Medication Class | Medication Name | Quality Care Dosing Limit per prescription |
---|---|---|
Antibiotics (topical) | Clindamycin Phosphate 1% foam | 100 GM |
Clindamycin Phosphate 1% gel | 150 GM | |
Clindamycin Phosphate 1% lotion | 120 ml | |
Clindamycin Phosphate 1% solution | 60 ml | |
Clindamycin Phosphate 2% cream | 80 GM | |
Mupirocin 2% cream | 60 GM | |
Mupirocin 2% ointment | 44 GM | |
Anticholinergics (inhaled) | Tudorza Pressair 400 mcg inhaler | 2 inhalers |
Yupelri 175 mcg/3 ml solution | 30 vials | |
Antifungals (topical) | Econazole Nitrate 1% cream | 170 GM |
Ketoconazole 2% cream | 120 GM | |
Ketoconazole 2% shampoo | 240 ml | |
Antimuscarinics (inhaled) | Spiriva Handihaler 18 mcg inhaler | 30 capsules |
Beta Agonists (long-acting, inhaled) | Brovana 15 mcg/2 ml solution | 120 ml |
Perforomist 20 mcg/2 ml solution | 60 ml | |
Combinations (inhaled) | Stiolto RespiMat inhaler | 1 inhalation cartridge (4 GM) |
Corticosteroids (inhaled) | Alvesco 80 mcg inhaler | 6.1 GM (1 inhaler) |
Asmanex Twisthaler 110 mcg, 220 mcg inhaler |
1 inhaler | |
Flovent Diskus 50 mcg, 100 mcg, 250 mcg | 60 blisters | |
Flovent HFA 44 mcg, 110 mcg, 220 mcg |
1 inhaler | |
Pulmicort Flexhaler 90 mcg inhaler | 1 inhaler | |
Pulmicort Flexhaler 180 mcg inhaler | 2 inhalers | |
Pulmicort Respule 0.25 mg/2 ml, 0.5 mg/2 ml | 60 ml (30 ampules) | |
Pulmicort Respule 1 mg/2 ml | 30 ml (15 ampules) | |
QVAR 40 mcg inhaler | 10.6 GM (1 inhaler) | |
SSRI (Antidepressants) | Prozac 40 mg, Fluoxetine 40 mg | Limits removed1 |
Zoloft 100 mg, Sertraline 100 mg |
-
Quality Care Dosing limits were removed for these medications on July 1, 2020.
Medications That Now Require Step Therapy
Step Therapy is a key part of our Prior Authorization program. It enables us to help doctors provide members with an appropriate and affordable medication treatment. Before coverage is allowed for certain costly “second-step” medications, we require that members first try an effective, but less expensive, “first-step” medication. Some medications may have multiple steps.
The following medications now require Step Therapy. This change only applies to new prescriptions. Members with a claim for any of these medications within the previous 130 days can continue their therapy without interruption.
Medication Class | Step 1 Medication | Step 2 Medication | Step 3 Medication |
---|---|---|---|
Migraine Treatment | Naratriptan Rizatriptan Sumatriptan |
Almotriptan Eletriptan Frovatriptan Sumatriptan/Naproxen Zolmitriptan Zomig nasal spray |
Amerge Axert Frova Imitrex Imitrex Injection Maxalt Maxalt MLT Relpax Treximet Zomig tablets |
Looking for More Information?
For more information about any of these medications, use the Medication Lookup tool.
Questions?
If you have any questions, please call Member Service at the number on the front of your ID card.
Coverage Update for Truvada
On July 1, 2020, we’ll begin covering Truvada, an HIV pre-exposure prophylaxis (PrEP) medication, at no additional cost for members who aren’t currently filling other HIV medications. Members taking other HIV medications, or are switching from an HIV medication to Truvada, will have to pay their usual out-of-pocket costs, including copays, co-insurance, and deductibles. This change applies to new prescriptions and refills, and to plans with either the Blue Cross Blue Shield of Massachusetts Formulary or National Preferred Formulary. However, the change doesn’t apply to grandfathered plans that don’t comply with the Affordable Care Act.
When the generic version of Truvada is released, we’ll start covering the generic version (instead of Truvada) at no additional cost for members who aren’t currently filling other HIV medications. At that time, members who continue to take Truvada, whether they’re taking additional HIV medications or not, will have to pay their usual out-of-pocket costs, including copays, co-insurance, and deductibles.
If you have any questions, please call Member Service at the number on the front of your ID card.
Coverage Change for Breast Cancer Risk-Reduction Medications
On October 1, 2020, we’ll begin covering the following generic oral medications in the class of aromatase inhibitors at no additional cost for members when the medications are prescribed to reduce breast cancer risk:
- Anastrozole
- Exemestane
- Letrozole
This change applies to plans with either the Blue Cross Blue Shield of Massachusetts Formulary or the National Preferred Formulary. However, this change doesn’t apply to grandfathered plans that don’t comply with the Affordable Care Act.
If you have any questions, please call Member Service at the number on the front of your ID card.
Upcoming 4th-Quarter Changes to the Blue Cross Blue Shield of Massachusetts Formulary
In the fourth quarter of 2020, we're updating our formulary (list of covered medications) for medical plans with pharmacy benefits, as well as Medex®´ plans with a three-tier pharmacy benefit. This update includes changes that were originally scheduled to go into effect on May 1 and July 1. As part of these updates, certain medications may:
- No longer be covered (exceptions may be granted)
- Be excluded from coverage (exceptions won’t be granted)
- Switch tiers
- Have new quantity or dosing limits
- Require step therapy
Questions?
Complete details about these changes will be available 60 days before the effective date at bluecrossma.org/disclaimer/plan-updates/pharmacy-benefit-updates. If you have any questions, please call Member Service at the number on the front of your ID card.
Medications That Now Require Prior Authorization, Effective April 1, 2020
Effective April 1, 2020, until further notice, the following medications will have quantity limits for first-time prescriptions for new therapies:
- Chloroquine Phosphate
- Hydroxychloroquine
- Plaquenil
If a medication is prescribed for more than 10 days, your doctor will be required to obtain Prior Authorization from us before additional medication can be covered and dispensed.
If you have any questions, please call Member Service at the number on the front of your ID card.
July 1st Formulary Changes Temporarily Delayed
In a recent Direct to You newsletter we notified you of upcoming formulary (list of covered medications) changes for July 1st that affected medical plans with pharmacy benefits as well as Medex® ́ plans with a three-tier pharmacy benefit. These changes have been temporarily delayed.
If you have any questions, please call Member Service at the number on the front of your ID card.
May 1st Formulary Changes Temporarily Delayed
We recently notified you of upcoming formulary (list of covered medications) changes for May 1st that affected medical plans with pharmacy benefits as well as Medex®´ plans with a three-tier pharmacy benefit. These changes have been temporarily delayed.
If you have any questions, please call Member Service at the number on the front of your ID card.
Upcoming changes to the Blue Cross Blue Shield of Massachusetts formulary, effective May 1,2020 - Delayed
Beginning May 1, 2020, we’re updating our formulary (list of covered medications) for medical plans with pharmacy benefits, as well as Medex®' plans with a three-tier pharmacy benefit. As part of these updates, certain medications may:
- No longer be covered (exceptions may be granted)
Medications no longer covered starting May 1, 2020
After carefully reviewing each medication’s cost and covered alternatives, we've removed the medications listed in the table below from our list of covered medications. However, your doctor may request an exception if these medications are medically necessary. If the exception is approved, you’ll pay the highest-tier cost.
Medication Class | Medication Name | Covered Alternative |
---|---|---|
Acne (topical) | Retin-A cream | Tretinoin cream |
Antidepressants | Fluoxetine tablets Venlafaxine ER tablets |
Fluoxetine capsules Venlafaxine ER capsules |
Antineoplastics | Arimidex Aromasin Gleevec |
Anastrozole Exemestane Imatinib |
Diabetes | Invokamet Invokamet XR Invokana |
Farxiga Jardiance Synjardy Synjardy XR Xigduo XR |
Migraine | Imitrex 6mg/0.5ml injection | Sumatriptan 6mg/0.5ml injection |
Ophthalmic combinations | Tobradex Zylet |
Neomycin/Bacitracin/ Polymyxin B/Hydrocortisone, Neomycin/ Polymyxin B/ Dexamethasone, Neomycin/ Polymyxin B/Hydrocortisone, Sulfacetamide/Prednisolone, Tobramycin/Dexamethasone |
Questions?
If you have any questions, please call Member Service at the number on the front of your ID card.
Changes to our speciality pharmacy network
Beginning March 31, 2020, BriovaRx®'' will no longer participate in our specialty pharmacy network. This change applies to the Blue Cross Blue Shield of Massachusetts formulary, and the National Preferred Formulary (NPF). This doesn't affect members who have Medicare Advantage with a Part D prescription drug plan; they can continue to use BriovaRx without interruption.
Unless you have Medicare Advantage with a Part D plan, you’ll no longer be covered for specialty medications purchased through BriovaRx. We’ll contact members who fill their prescriptions at BriovaRx to let them know that the pharmacy has left our network, and help them transition to an in-network specialty pharmacy.
Specialty pharmacies provide specialty medications that are used to treat certain complex health conditions. For more information about specialty medications, use the Medication Lookup tool.
If you have any questions, please call Member Service at the number on the front of your ID card.
Changes to your prescription coverage
Beginning January 1, 2020, we’re updating our list of covered medications for medical plans with pharmacy benefits, as well as Medex®' plans with a three-tier pharmacy benefit. As part of these updates, certain medications may:
- No longer be covered (exceptions may be granted)
- Be excluded from coverage (exceptions won’t be granted)
- Switch tiers
- Have new quantity or dosing limits
Medications no longer covered in 2020
After carefully reviewing each medication's cost and covered alternatives, we've removed the medications listed in the table below from our covered medications list. However, your doctor may request an exception if these medications are medically necessary. If the exception is approved, you’ll pay the highest-tier cost.
Medication Class | Medication Name | Covered Alternative |
---|---|---|
Epinephrine Injections | Adrenaclick (Authorized Generic Product) | Epinephrine Auto-Injector EpiPen Auto-Injector |
Inhaled Anticholinergic for chronic obstructive pulmonary disease | Tudorza inhaler | Spiriva RespiMat Spiriva HandiHaler |
Laxative | Lactulose 10 gm packet | Lactulose syrup |
Stimulants | Strattera* | Atomoxetine |
Nonsteroidal Anti-Inflammatory | Fenoprofen 200 mg and 400 mg capsules | Fenoprofen 600 mg tablets |
Ophthalmic Dry eye Treatment | Restasis MultiDose | Restasis Single Use vials (requires prior authorization) |
Oral Acne Treatment | Doxycycline IR-DR | Doxycycline Hyclate Doxycycline Monohydrate |
Oral Antihistamine | Carbinoxamine 6 mg tablets | Carbinoxamine 4 mg tablets |
Oral Muscle Relaxants | Chlorzoxazone 250 mg, 375 mg, and 750 mg tablets | Chlorzoxazone 500 mg tablets |
Topical Acne Treatment | Aktipak gel pouch | Erythromycin/Benzoyl Peroxide |
Topical Vitamin D | Sorilux Foam | Calcipotriene Cream |
Weight Loss | Belviq Belviq XR |
Saxenda Contrave ER |
*If you currently take Strattera, your medication will continue to be covered until the current authorization expires. However, you’ll pay the highest-tier cost.
Medications excluded from coverage
The following medications will be excluded from our pharmacy benefit as of January 1, 2020. You’ll be responsible for the full cost of these medications when filling a prescription at the pharmacy. This change will apply to all commercial plans, group Medex®'plans with pharmacy benefits, and Managed Blue for Seniors. Formulary exceptions won’t be accepted for these medications
Medication or Supply Name
- Bensal HP1
- Epiduo1
- Pliaglis2
- Prilocaine 7%/Tetracaine 7%2
- Sil-k 2” X 5” Pad3
- Over-the-counter alternatives that don’t require a prescription are available for this medication.
- This medication isn’t available over-the-counter and is only available for medical professional use.
- Coverage for bandages isn’t included under our pharmacy benefit.
- This medication is available over-the-counter without a prescription.
Medications switching tiers
When the cost of a medication changes, we may move it to a different tier. The medications listed below are moving to a higher tier under certain pharmacy plans and may cost more.
Medication Class | Medication Name | 2020 Tier for members with a three-tier pharmacy benefit |
2020 Tier for members with a four-tier pharmacy benefit |
2020 Tier for members with a five-tier pharmacy benefit |
2020 Tier for members with a six-tier pharmacy benefit |
---|---|---|---|---|---|
Topical Antiviral | Acyclovir Ointment | Tier 2a | Tier 3b | Tier 2a | Tier 3b |
Granulocyte Stimulating Factor | Nivestym | Tier 3b | Tier 4c | Tier 5d | Tier 6e |
- This medication was previously covered at Tier 1.
- This medication was previously covered at Tier 2.
- This medication was previously covered at Tier 3.
- This medication was previously covered at Tier 4.
- This medication was previously covered at Tier 5.
Medications with new quality care dosing limits
To make sure that the quantity and dose of a medication meet the Food and Drug Administration, manufacturer, and clinical recommendations, we’re reducing Quality Care Dosing Limits for the following medications:
Medication Name |
Quality Care Dosing Limit per prescription |
---|---|
Calcipotriene 0.0005% cream, ointment, topical solution Dovonex 0.0005% cream, ointment, topical solution |
180 gm (all formulations) |
Doxepin 5% cream Prudoxin 5% cream Zonalon 5% cream |
90 gm total |
Albuterol HFA authorized products ProAir HFA ProAir RespiClick Ventolin HFA Proventil HFA Xoponex HFA |
2 inhalers |
Oxiconazole nitrate 1% cream Oxistat cream |
90 gm each |
Triamcinolone 0.147mg/spray aerosol Kenalog aerosol (T3) |
2 aerosol cans (126 gm) |
Expanded access to certain cholesterol medications
In 2020, you’ll be able to fill prescriptions for Praluent and Repatha at any retail pharmacy that has access to these medications in the Express Scripts®' network.* Previously, these medications, which are known as PCSK9 agents and are typically used to lower cholesterol levels, were only available through in-network specialty pharmacies.
*Please note that these medications may not be available at all pharmacies.
Coverage of Opioid Alternatives, and Change in Massachusetts’ "Partial Fill" Law
For members who prefer not to use opioids, a class of medication that includes OxyContin and Vicodin and is sometimes prescribed by doctors to treat pain, our standard plans cover a wide range of alternative treatment options, including more than 500 non-opiate medications (nonsteroidal anti-inflammatory drugs, and topical analgesics).*
We also cover several specialty services, combining therapies to offer individualized treatment for pain management, including:
- physical and occupational therapy (PT/OT)
- chiropractic treatment
- pain medicine specialists
- transcutaneous electrical nerve stimulation (TENS) units
- acupuncture (beginning January 1, 2020 for new or renewed plans)
We’ll be adding an Alternatives to Opioids section to the Medication Lookup tool by the end of December. That’s where you’ll find an Alternatives to Opioids fact sheet and medication list.
Also, due to a recent change in Massachusetts’ “partial fill” law, there’s no extra charge if you choose to partially fill your narcotic or opioid prescription. You won’t be charged an additional copay if you fill the remainder of your prescription at the same pharmacy within 30 days.
*For more information about coverage for non-opiate medications, members should check their pharmacy benefit materials. For covered pain management services, they should check their medical benefit materials.
National Prescription Drug Take Back Day is October 26, 2019
Medications don’t last forever. Over time, their chemical properties change, making them less potent—and even dangerous. Take the time to go through your medicine cabinets and check for any expired or unwanted medications—this includes everything from aspirin to prescription medications.
The U.S. Drug Enforcement Administration’s next National Prescription Drug Take Back Day is Saturday, October 26, 2019, from 10:00 a.m. to 2:00 p.m. Anyone can take part by bringing expired or unused medications to a local disposal location.
Use the U.S. Drug Enforcement Administration's search tool to find a collection site near you.
Changes to our speciality pharmacy network and medication list
Beginning July 1, 2019, we’ll make the following changes to our retail specialty pharmacy network and to the medications these pharmacies can fill.
AllianceRx Walgreens Prime will leave our retail specialty pharmacy fertility network
AllianceRx Walgreens Prime will no longer be in our retail specialty pharmacy fertility network. If you’re receiving specialty fertility medications through AllianceRx Walgreens Prime, you can complete the medications for your current cycle, but we won’t cover prescriptions filled at AllianceRx Walgreens Prime on or after July 1, 2019. If this change impacts you, we’ll reach out to you directly.
BriovaRx® will leave our fertility network, but remain in our specialty network
BriovaRx will no longer be in our fertility network, but will continue to fill other prescriptions in our Specialty Network. If you’re receiving fertility medications through BriovaRx, you can complete the medications for your current cycle, but we won’t cover fertility prescriptions filled at BriovaRx on or after July 1, 2019. If this change impacts you, we’ll reach out to you directly.
Updates to our specialty pharmacy medication list
Beginning July 1, 2019, we’ll cover additional medications and new-to-market medications in our specialty pharmacy network.
Medications now available through our specialty pharmacy network:
- Cinryze
- Haegarda
- Berinert
- Kalbitor
- Ruconest
New-to-market medications:
- Abiraterone
- Alyq
- Carmustine
- Daurismo
- Inbrija
- Ledipasvir/Sofosbuvir
- Lorbrena
- Lumoxiti
- Oxervate
- Panzyga
- Sofosbuvir/Velpatasvir
- Talzenna
- Tegsedi
- Udenyca
- Vitrakvi
- Vizimpro
Questions?
If you have any questions, please call Member Service at the number on the front of your ID card.
Introducing our new Medication Lookup Tool
With our new and improved Medication Lookup tool, you can easily determine which medications are covered by your plan. You’ll also find covered alternatives to non-covered medications, as well as which medications have additional requirements before being prescribed. You can use the tool to:
- Search for any medication
- View medications by strength
- See medications by how they’re dispensed, such as pills, liquids, and injections
- Learn which medications have additional requirements, such as Prior Authorization, Step Therapy, and Quality Care Dosing
- See covered alternatives for non-covered medications
View medications by tier*
To use the tool, go to Medication Lookup tool.
Questions?
If you have any questions, please call Member Service at the number on the front of your ID card.
*A medication’s tier is based on your plan design. Knowing how many tiers your plan has can help you understand your out-of-pocket costs. Instructions to find which plan you have are included within the tool.
Coming in July 2019: upcoming changes to our pharmacy program
Beginning July 1, 2019, we’re making changes to our list of covered medications for medical plans with pharmacy benefits, as well as Medex® plans with a three-tier pharmacy benefit. We’ll notify impacted members by June 1, 2019. As part of these updates, certain medications may:
- No longer be covered
- Switch cost tiers
- Be excluded from pharmacy benefit coverage due to over-the-counter availability
- Require prior authorization
Certain medication will become non-covered
After a careful review of its cost and covered alternatives, we’ve decided to remove the medication in the table below from our list of covered medications, effective July 1, 2019. Your doctor or prescriber may request a coverage exception if the medication is medically necessary. If the request is approved, you’ll pay the highest-tier cost for the medication.
Medication Class | Medication Name | Covered Alternative |
---|---|---|
Erythropoietins | Procrit* | Retacrit |
*If you’re currently prescribed to Procrit, you may continue to fill your prescription under your existing prior authorization. However, you’ll pay more as the medication will move to the highest tier.
Medications that are switching tiers
When the cost of a medication changes, we may move the medication to a different tier. The medications listed below are moving to a higher tier, which means they may cost you more.
Medication Class | Medication Name | 2019 Tier For members with a three-tier pharmacy benefit |
2019 Tier For members with a four-tier pharmacy benefit |
2019 Tier For members with a five-tier pharmacy benefit |
2019 Tier For members with a six-tier pharmacy benefit |
---|---|---|---|---|---|
Topical Testosterone | Tier 3a | Tier 4b | Tier 3a | Tier 4b | |
Granulocyte Stimulant Factor | Tier 3a | Tier 4b | Tier 5c | Tier 6d |
a This medication was previously covered at Tier 2.
b This medication was previously covered at Tier 3.
c This medication was previously covered at Tier 4.
d This medication was previously covered at Tier 5.
Medications excluded from pharmacy benefit coverage
The following medications will be excluded from our pharmacy benefit due to over-the-counter availability. This change will apply to all commercial plans, group Medex® plans with pharmacy benefits, and Managed Blue for Seniors. Formulary exceptions won’t be accepted for these medications.
Medication Name
- Differin 0.1% (All topical forms)
- Adapalene 0.1% (All topical forms)
- Proton pump inhibitors when included as part of a compounded medication*
*Members under the age of 18 will still be covered for these medications. However, prior authorization will be required for new prescriptions.
Medications requiring prior authorization
For certain medications, your doctor must first obtain approval before we cover it. The following medications will require prior authorization:
- Axiron*
- AndroGel*
- Berinert
- Firazyr
- Gilotrif*
- Haegarda
- Iressa*
- Kalbitor
- Neulasta
- Neupogen
- Ruconest
- Tarceva*
- Tagrisso*
*If you’re currently prescribed to this medication, you may continue to fill your prescription and won’t require prior authorization.
Updates to our prior authorization requirements
Beginning July 1, 2019, our prior authorization requirements for the medications listed below are changing for members with our HMO, Access Blue, and Blue Choice® plans.
Medication Name | AdministrationBerinert |
---|---|
|
Prior authorization is required for these medications when administered: In a clinician’s or physician’s office By a home health care provider By a home infusion therapy provider In an outpatient hospital and dialysis setting |
This change doesn’t affect these medications when administered in inpatient care, surgical day care, urgent care centers, and emergency room settings.
Upcoming changes to our pharmacy program
Beginning January 1, 2019, we're making changes to our list of covered medications for medical plans with pharmacy benefits, as well as Medex® plans with a three-tier pharmacy benefit. As part of these updates, certain medications may:
- No longer be covered
- Switch tiers
- Have a new dosing limit
- Require prior authorization
- Change cost
Proton pump inhibitors no longer a covered benefit in 2019
Effective January 1, 2019, proton pump inhibitors (medications commonly used to reduce stomach acid) will be excluded from your pharmacy benefit, except for members under the age of 18.
- This benefit exclusion will apply to members 18 years of age and older who currently have pharmacy benefits.
- This benefit exclusion will not apply to members under the age of 18.
- This benefit exclusion will not apply to members being treated with combination prescription medications to treat Helicobacter pylori (H. pylori).
Exceptions will no longer be available for this class of medications, even if the member has a prescription or if we've covered it in the past.
Members should talk to their doctors about over-the-counter medication options that are available without a prescription.
This affects the following medications:
- Aciphex
- First-Lansoprazole
- Omeprazole sodium bicarbonate
- Rabeprazole
- Aciphex Sprinkle
- First-Omeprazole
- Pantoprazole
- Zegerid
- Dexilant
- Lansoprazole
- Prevacid
- Esomeprazole magnesium
- Nexium
- Prilosec
- Esomeprazole strontium
- Omeprazole
- Protonix
Medications no longer covered in 2019
After carefully reviewing each medication's cost and covered alternatives, we've removed the medications listed in the table below from our covered medications list. However, a doctor may request an exception if these medications are medically necessary. If the exception is approved, the member will pay the highest-tier cost.
Medication Class | Non-Covered Medication or Supply | Covered Alternative |
---|---|---|
Anticoagulants (medications to treat and prevent blood clots) |
Pradaxa* | Eliquis, Xarelto, warfarin |
Colchicine Products (medications to treat gout) |
Single-source colchicine products (colchicine products that resemble generic versions in name only) | Colcrys, Mitigare |
Dopamine Agonists (treatment for Parkinson's disease) |
Mirapex | ropinirole, pramipexole |
Glucagon-Like Peptide 1 Agonists (injectable medications to treat diabetes) |
Victoza | Byetta, Bydureon, Trulicity |
Granulocyte Stimulants (white blood cell replacement agents used during chemotherapy) |
Neupogen**†† | Zarxio††, Granix†† |
Ophthalmic Anti-Inflammatory (short-term medications to treat inflammation in the eye) |
FML S.O.P., FML Liquifilm, Pred Mild, Maxidex, Flarex | Lotemax, generic ophthalmic steroid medications |
*Members currently using Pradaxa will be given an exception to continue their coverage until December 31, 2019, but they'll pay the highest-tier cost since the medication will no longer be covered.
**Members currently using Neupogen will be given an exception to continue their coverage until May 31, 2019, but they'll pay the highest-tier cost since the medication will no longer be covered.
††This medication must be filled at an in-network retail specialty pharmacy.
Medications that are switching tiers
When the cost of a medication changes, we may move the medication to a different tier. Depending on the tier change, your payment for the following medications may increase or decrease:
These medications are moving to a higher tier, which means they may cost you more.
Medication Class |
Medication Name |
2019 Tier (for members with a three-tier pharmacy benefit) |
2019 Tier (for members with a four-tier pharmacy benefit) |
2019 Tier (for members with a five-tier pharmacy benefit) |
2019 Tier (for members with a six-tier pharmacy benefit) |
---|---|---|---|---|---|
Infliximab Products (immunosuppressive medications to treat psoriasis, rheumatoid arthritis, Crohn's disease, etc.) |
Remicade†† Renflexis†† |
Tier 3a | Tier 4b | Tier 5c | Tier 6d |
Multiple Sclerosis: Oral Agents | Aubagio†† | Tier 3a | Tier 4b | Tier 5c | Tier 6d |
These medications are moving to a lower tier, which means they may cost you less.
Medication Class | Medication Name | 2019 Tier (for members with a three-tier pharmacy benefit) |
2019 Tier (for members with a four-tier pharmacy benefit) |
2019 Tier (for members with a five-tier pharmacy benefit) |
2019 Tier (for members with a six-tier pharmacy benefit) |
---|---|---|---|---|---|
DPP4/SGLT2 Inhibitor Combinations (oral medications to treat diabetes) |
Glyxambi | Tier 2e | Tier 3e | Tier 2e | Tier 3e |
Insulins - Basal | Basaglar | Tier 2e | Tier 3e | Tier 2e | Tier 3e |
Multiple Sclerosis: Beta-Interferons | Plegridy†† | Tier 2e | Tier 3e | Tier 4e | Tier 5e |
Novel Psychotropics: Long Acting (medications to treat psychological disorders) |
Abilify- Maintena | Tier 2e | Tier 3e | Tier 2e | Tier 3 |
a This medication was previously covered at Tier 2.
b This medication was previously covered at Tier 3.
c This medication was previously covered at Tier 4.
d This medication was previously covered at Tier 5.
e This medication wasn't previously covered.
†† This medication must be filled at an in-network retail specialty pharmacy.
Medications with new Quality Care Dosing Limit
To make sure that the quantity and dose of a medication meet the Food and Drug Administration, manufacturer, and clinical recommendations, we're reducing Quality Care Dosing Limits for the following medications:
Medication Name | Quality Care Dosing Limit |
---|---|
Morphabond ER 60mg | 60 per prescription |
Morphabond ER 100mg | 30 per prescription |
Medications requiring prior authorization (for new prescriptions only)
Your doctor is required to obtain prior authorization before we'll cover certain medications. The following medications will require prior authorization for new prescriptions in 2019. Members currently taking the medications will be given an exception and won't need prior authorization:
- Breo Ellipt
Higher costs for medications with supplies longer than 30 days
The cost for the medications listed below is increasing. These medications are usually dispensed in a supply longer than 30 days. We've typically only charged members a 30-day copayment for these medications. Beginning January 1, 2019, members will have to pay an adjusted copayment based on the supply length.†
For example: if your copayment is $25 for a 30-day supply, you'll pay $75 for a 90-day supply.
- fluphenazine decanoate
- Lupron Depot Pediatric††
- Eligard††
- Zoladex††
- leuprolide acetate††
- haldol decanoate
- Lupron Depot††
- haloperidol decanoate
† This change only applies to members with a prescription plan that uses a copayment.
†† This medication must be filled at an in-network retail specialty pharmacy.
How to save money for long-term prescriptions
You may be able to save money for long-term medications, also known as maintenance medications, when you order prescriptions through our mail order pharmacy. Learn more at MyBlue, or get started online by visiting Express Scripts®, an independent company that manages your pharmacy benefits on behalf of Blue Cross Blue Shield of Massachusetts. You can also call them directly at 1-800-892-5119.
Questions about your treatment options
If these changes affect you and you have questions about your treatment options, such as whether a less expensive medication is available, please talk to your doctor.
New changes to our speciality pharmacy network
Effective September 1, 2018, we'll be making the following changes to our specialty pharmacy network:
- BriovaRx®will join.
- AllianceRx Walgreens Prime will leave, but will remain within our fertility network.
- AllCare Plus Pharmacy and On co360 will also leave.
If you fill your prescription at one of the pharmacies that will be leaving our network, you'll receive a letter from us by August 1 to help you transition to an in-network pharmacy.
Specialty pharmacies provide medications that are used to treat certain complex health conditions.
Questions?
If you have any questions or need help transitioning to an in-network pharmacy, please call Member Service at the number on the front of your ID card.
Upcoming changes to our specialty pharmacy network
Beginning September 1, 2018, we’re making changes to our specialty pharmacy network. As part of these changes AllCare Plus Specialty Pharmacy and On co360 will be leaving the network. Prescriptions for specialty medications from AllCare Plus and On co360 will no longer be covered. If you fill your prescription at either of these pharmacies, we’ll contact you by August 1, 2018 to help you transition to an in-network specialty pharmacy. Specialty pharmacies provide medications that are used to treat certain complex health conditions. You can view our Specialty Medications list.
Introducing Diabetes Care Value, a new way to engage and support members with diabetes
We're excited to introduce Diabetes Care Value, our newest program to support members with diabetes who are over 18. This program helps members regularly monitor blood glucose levels and manage diabetes medications, and offers incentives for making healthy choices. Beginning July 1, 2018, eligible members will receive communications in the mail from our partners, Express Scripts® and Mango Health*, with instructions on how to enroll.
The Diabetes Care Value program features:
- Tracking and monitoring of blood glucose readings with a OneTouch Verio Flex® meter, available at no additional cost. This meter pairs with the OneTouch Reveal® mobile app to track blood glucose readings.
- Access to specially trained pharmacists who monitor glucose readings through the OneTouch Reveal app and provide tailored coaching when issues are identified over time.
- Rewards and incentives for staying on track with diabetes medications and making healthy choices through Mango Health, a medication management app. Available at no additional cost, Mango Health is IOS and Android compatible.
Questions? Contact Express Scripts at 855-723-6099 and ask to speak to a pharmacist specializing in diabetes.
*Express Scripts and Mango Health are independent companies, working on behalf of Blue Cross Blue Shield of Massachusetts.
Update regarding changes to continuous glucose monitor sensor coverage
In March, we featured an article in our Direct to You newsletter and online on our MyBlue® Pharmacy Updates page stating that beginning July 1, 2018, we would provide coverage for continuous glucose monitor (CGM) sensors under the Durable Medical Equipment (DME) benefit.
We have decided that coverage for CGM sensors will remain unchanged. As a result, CGM sensors will continue to be covered by your medical plan's pharmacy benefit.
If you have any questions, call the Member Service number on the front of your ID card.
You can refer to the original change announcement below.
Changes to continuous glucose monitor sensor coverage
Beginning July 1, 2018, we'll provide coverage for continuous glucose monitors (CGMs) sensors under the Durable Medical Equipment (DME) benefit. Previously, CGM sensors were covered under the pharmacy benefit.
The move to DME was made, in part, to ease confusion regarding coverage requirements for the CGM sensors. If you don't have pharmacy coverage but already have coverage for the CGM sensors under DME benefits, there's no change to your plan.
We will notify impacted members of this change by letter prior to June 1, 2018.
If you have any questions, call the Member Service number on the front of your ID card.
New prior authorization requirements for HMO, Access Blue, and Blue Choice®plans
Beginning July 1, 2018, prior authorization is required for the medications listed below when administered:
- In a doctor's office
- By home health care providers
- By home infusion therapy providers
- In outpatient hospital and dialysis settings
This change doesn't affect these medications when used in inpatient, surgical day care, urgent care centers, and ER settings. We encourage you to discuss this change with your health care provider.
Medications that require prior authorization:
- Cosentyx
- Hemlibra
- Inflectra
- Kevzara
- Rebinyn
- Renflexis
- Siliq
- Taltz
- Tremfya
- Tretten
Coming in July 2018: changes to our pharmacy program
Beginning July 1, 2018, we're making changes to our covered medications list for medical plans with pharmacy benefits, and Medex®plans with the three-tier pharmacy benefit. As part of these updates, certain medications will do one of the following:
- Switch tiers
- No longer be covered
- Have a new dosing limit
Medications that are switching tiers
When the cost of a medication changes, we move the medication to a different tier. Depending on the tier change, your payment for the following medications may increase or decrease:
Medication Class | Medication Name | New Tier as of July 1, 2018 (applies to members with a 3-tier or 5-tier pharmacy benefit) | New Tier as of July 1, 2018 (applies to members with a 4-tier or 6-tier pharmacy benefit) |
---|---|---|---|
Dermatological | Doxepin cream | Tier 21 | Tier 32 |
Inhaled combination for chronic obstructive pulmonary disease | Tier Anoro Ellipta | Tier 21 | Tier 32 |
1 This medication was previously covered at Tier 1.
2 This medication was previously covered at Tier 2.
Medications no longer covered
After carefully reviewing each medication's cost and covered alternatives, we've removed the medications listed in the chart below from our covered medications list. However, when these medications are medically necessary, your prescribing doctor may request a coverage exception.
Medication Class | Non-Covered Medication or Supply | Covered Alternative |
---|---|---|
Multi-Source Brands | Provigil Lidoderm Patch | Modafinil Lidocaine Patch |
Medications with a new Quality Care Dosing Limit
To make sure that the quantity and dose of a medication meets the Federal Drug Administration, manufacturer, and clinical recommendations, we’re adding a Quality Care Dosing Limit to the following medications:
For This Medication | The Quality Care Dosing Limit for Each Prescription | Additional Information |
---|---|---|
Naloxone Carpuject (vial and syringes) | Two per 30 days | This medication will also be available at no cost for eligible members. If you have a Saver plan, the deductible will apply first. Please call Member Service at the number on your ID card, or check your benefit materials to see if you're eligible. |
Narcan nasal spray | Two per 30 day | |
Evzio | Two per 30 day | N/A |
Proton pump inhibitors to be excluded from pharmacy coverage in 2019
Beginning January 1, 2019, all proton pump inhibitors will be excluded from our pharmacy benefit coverage, except for members under the age of 18 and those taking combination medications to treat H. Pylori. Formulary exceptions, including those previously approved, will no longer be available for this class of medication, except for members under the age of 18 and those taking combination medications to treat H. Pylori.
This change applies to the following plans with pharmacy benefits:
- Individual plans
- Massachusetts Health Connector plans
- Medex plans with 3-tier pharmacy benefits
Walgreens Specialty Pharmacy Is Now AllianceRx Walgreens Prime
One of the specialty pharmacies in our retail network, Walgreens Specialty Pharmacy, has changed its name to AllianceRx Walgreens Prime. AllianceRx Walgreens Prime delivers specialty pharmacy services to individuals with complex medical conditions.
If you're already using this specialty pharmacy for any medication, no action on your part is required. AllianceRx Walgreens Prime will continue to fill prescriptions—just under its new name. Phone and fax numbers remain the same for now, but the website has been updated to reflect the name change.
How to reach AllianceRx Walgreens Prime:
Phone: 1-800-424-9002
Fax: 1-800-874-9179
Web: alliancerxwp.com
$0 Copay for some statin medications starting December 1, 2017
Pharmacy benefit update for statins, effective December 1, 2017
To comply with the Affordable Care Act, starting December 1, 2017, the following statin medications will be covered at no cost* for members that meet the conditions listed below.
- Atorvastatin 10-20 mg
- Fluvastatin IR and XL 20-80 mg
- Lovastatin 10-40 mg
- Pravastatin 10-80 mg
- Rosuvastatin 5-10 mg
- Simvastatin 5-40 mg
Members must meet the following criteria:
- No history of cardiovascular disease (CVD) (i.e., symptomatic coronary artery disease or ischemic stroke)
- Meet the age requirement (40 to 75)
- Have one or more CVD risk factors (dyslipidemia, diabetes, hypertension, or smoking)
- Have a calculated 10-year risk of a cardiovascular event of 10% or greater
Questions?
If you have any questions, please call Member Service at the number on the front of your Blue Cross ID card. For more information about your prescription coverage, visit bluecrossma.com/pharmacy. *For qualified members.
Pharmacy program changes coming in 2018
Beginning January 1, 2018, we're making changes to our covered medications list for medical plans with pharmacy benefits, and Medex® plans with the three-tier pharmacy benefit.
These changes affect:
- Medication coverage
- Medication dosing limits
Medications no longer covered as of 2018
After reviewing each medication's cost and covered alternatives, we've removed the medications listed in the chart below from our covered medications. However, when these medications are medically necessary, a member's doctor or prescriber may request a coverage exception; if approved, the medication will process at the highest tier
Medication Class | Non-Covered Medication or Supply | Covered Alternative |
---|---|---|
Biguanides for Diabetes | Generic Metformin Film Coated ER version of Fortamet | Metformin 500mg, 850mg, 1000mg(Generic version of Glucophage) Metformin ER 500mg, 750mg (Generic version of Glucophage XR) |
Estrogen and Estrogen Modifiers | Femring | Estrace Estring Premarin |
Glucagon-Like Peptide-1 Agents | Tanzeum* | Bydureon Byetta Trulicity |
Novel Psychotropics | Abilify Geodon Seroquel Zyprexa Zyprexa Zidis |
aripiprazole ziprasidone quetiapine olanzapine olanzapine ODT |
*Existing users may continue to fill this medication but will experience a tier change.
Medication with new Quality Care Dosing Limit
To make sure that the quantity and dose of a medication meets the Federal Drug Administration, manufacturer, and clinical recommendations, we are adding a Quality Care Dosing Limit to the following medications:
Medication Name | Quality Care Dosing Limit |
---|---|
Humira Pediatric Crohn's Starter Pack | 1 Pack (2 Syringes) |
*This impacts new starts only. There will be no impacted member communications
Proton pump inhibitors will be excluded from pharmacy coverage
Beginning January 1, 2019, all proton pump inhibitors will be excluded from our pharmacy benefit coverage, except for members under the age of 18 and those taking combination medications to treat H. Pylori. Formulary exceptions, including those previously approved, will no longer be available for this class of medication, except for members under the age of 18 and those taking combination medications to treat H. pylori.
This change applies to all commercial plans, group Medex plans with three-tier pharmacy benefits, and Managed Blue for Seniors plans. We will notify impacted members beginning in November 2018 prior to the change.
AllCare Plus Specialty Pharmacy is joining our network
This summer you'll have another retail specialty pharmacy option where you can fill prescriptions for specialty medications. Starting July 1, 2017, AllCare Plus Pharmacy is joining our retail specialty pharmacy network. Specialty pharmacies provide medications that are used to treat certain health conditions. These medications must be filled at a retail specialty pharmacy in our network. You can view our Specialty Medications List here. We're updating this list on July 1 to include the medications AllCare Plus fills. You can reach AllCare Plus at 1-855-880-1091 or allcarepluspharmacy.com.
Proton pump inhibitors will be excluded from pharmacy coverage
Beginning January 1, 2019, all proton pump inhibitors will be excluded from our pharmacy benefit coverage, except for members under the age of 18 and those taking combination medications to treat H. Pylori. Formulary exceptions, including those previously approved, will no longer be available for this class of medication, except for members under the age of 18 and those taking combination medications to treat H. pylori. This change applies to all commercial plans, group Medex plans with three-tier pharmacy benefits, and Managed Blue for Seniors plans. We're making this change because several products in this class are available over the counter.
New prior authorization requirements for HMO, Access Blue, and Blue Choice plans
Beginning September 1, 2017, prior authorization is required for the medications listed below when administered:
- In doctor offices
- By home health care providers
- By home infusion therapy providers
- In outpatient hospital and dialysis settings
This change doesn't affect these medications when used in inpatient, surgical day care, urgent care centers, and ER settings. We encourage you to discuss this change with your health care provider.
Medications that require prior authorization:
- Egrifta
- Exondys-51
- Gel-Syn
- Ixinity
- Kanuma
- Kovaltry
- Lemtrada
- NovoEight
- Obizur
- Spinraza
- Zomacton
Changes to our pharmacy program
Beginning September 1, 2017, we're making changes to our covered medications list that will affect:
- Medications switching tiers
- Medications that are no longer covered
- One medication moving to benefit exclusion (also impacts Managed Blue for Seniors)
Plans affected by the changes:
- Commercial medical plans with pharmacy benefits
- Medex® plans with the three-tier pharmacy benefit
Medications changing tier status
When the cost of a medication changes, we move the medication to a different tier. Depending on the tier change, you may be required to pay more or less for the following medications: Note:
Medication Class | Medication Name | Covered Tier Level as of September 1, 2017 under a 3 Tier Formulary | Covered Tier Level as of September 1, 2017 under a 4 Tier Formulary |
---|---|---|---|
Proton Pump Inhibitors (PPI) |
|
Tier 3 | Tier 4 |
Syringes |
|
Tier 2 | Tier 3 |
If you're using combination prescription medications to treat H. pylori, you'll continue to pay your current cost.
Medications no longer covered
After carefully reviewing each medication's cost and covered alternatives, we've removed the medications listed in the chart below from our covered medications list for the plans referenced above. However, when these medications are medically necessary, your doctor or prescriber may request a coverage exception.
Medication Class | Non-Covered Medication or Supply |
---|---|
Angiotensin II Receptor Blockers (for high blood pressure) | Azor, Benicar, Benicar HCT, and Tribenzor |
Antipsychotic Medications | Seroquel XR |
Asthma/Allergy Treatment | Singulair |
Cholesterol-Lowering Medications | Zetia |
Colonoscopy Preparation/ Laxatives | Osmoprep* |
Dermatological Treatments | Alcortin-A, Anusol HC Suppository, Lidocaine-HC 2%-2.5% Kit, Relador Pak, Relador Pak Plus, Salicylic Acid 6% Lotion Kit |
*Since Osmoprep is a one-time use medication, we will not issue member letters.
Medication excluded from pharmacy coverage
The following medication will be excluded from our pharmacy coverage because it's cosmetic. This change will apply to all commercial plans, group Medex® plans with pharmacy benefits, and Managed Blue for Seniors. Formulary exception will not be accepted for this medication
- Medication Name
- Avenova Lid-Lash Spray
UPDATE - Effective January 1, 2025, changes to the Standard Control with Advanced Control Specialty Formulary
Effective January 1, 2025, CVS Caremark®', an independent company that administers your pharmacy benefits on behalf of Blue Cross Blue Shield of Massachusetts, is updating their formulary (list of covered medications) for medical plans with the Standard Control with Advanced Control Specialty Formulary (SC-ACSF). As part of this update, certain medications may:
- No longer be covered (exceptions may be granted)
- Switch tiers
- Have new quantity or dosing limits
- Require prior authorization and/or step therapy
- Be added to the list of covered medications
- Be designated as preferred
To see the SC-ACSF changes and current medication lists, go to the Medication Lookup tool.
Effective January 1, 2025, Changes to the Standard Control with Advanced Control Specialty Formulary
Effective January 1, 2025, CVS Caremark®', an independent company that administers your pharmacy benefits on behalf of Blue Cross Blue Shield of Massachusetts, is updating their formulary (list of covered medications) for medical plans with the Standard Control with Advanced Control Specialty Formulary. As part of this update, certain medications may:
- No longer be covered (exceptions may be granted)
- Switch tiers
- Have new quantity or dosing limits
- Require prior authorization and/or step therapy
- Be added to the list of covered medications
- Be designated as preferred
Complete details about these changes will be available by October 31, 2024. Check back at that time.
UPDATE - Effective January 1, 2025, changes to the Standard Control with Advanced Control Specialty Formulary
Effective January 1, 2025, CVS Caremark®', an independent company that administers your pharmacy benefits on behalf of Blue Cross Blue Shield of Massachusetts, is updating their formulary (list of covered medications) for medical plans with the Standard Control with Advanced Control Specialty Formulary (SC-ACSF). As part of this update, certain medications may:
- No longer be covered (exceptions may be granted)
- Switch tiers
- Have new quantity or dosing limits
- Require prior authorization and/or step therapy
- Be added to the list of covered medications
- Be designated as preferred
To see the SC-ACSF changes and current medication lists, go to the Medication Lookup tool.
Effective January 1, 2025, Changes to the Standard Control with Advanced Control Specialty Formulary
Effective January 1, 2025, CVS Caremark®', an independent company that administers your pharmacy benefits on behalf of Blue Cross Blue Shield of Massachusetts, is updating their formulary (list of covered medications) for medical plans with the Standard Control with Advanced Control Specialty Formulary. As part of this update, certain medications may:
- No longer be covered (exceptions may be granted)
- Switch tiers
- Have new quantity or dosing limits
- Require prior authorization and/or step therapy
- Be added to the list of covered medications
- Be designated as preferred
Complete details about these changes will be available by October 31, 2024. Check back at that time.
UPDATE - Effective October 1, 2024, Changes to the Standard Control with Advanced Control Specialty Formulary
Effective October 1, 2024, CVS Caremark®', an independent company that administers your pharmacy benefits on behalf of Blue Cross Blue Shield of Massachusetts, is updating their formulary (list of covered medications) for medical plans with the Standard Control with Advanced Control Specialty Formulary (SC-ACSF). As part of this update, certain medications may:
- No longer be covered (exceptions may be granted)
- Switch tiers
- Have new quantity or dosing limits
- Require prior authorization and/or step therapy
- Be added to the list of covered medications
- Be designated as preferred
To see the SC-ACSF changes and current medication lists, go to the Medication Lookup tool.
Effective October 1, 2024, Changes to the Standard Control with Advanced Control Specialty Formulary
Effective October 1, 2024, CVS Caremark®', an independent company that administers your pharmacy benefits on behalf of Blue Cross Blue Shield of Massachusetts, is updating their formulary (list of covered medications) for medical plans with the Standard Control with Advanced Control Specialty Formulary. As part of this update, certain medications may:
- No longer be covered (exceptions may be granted)
- Switch tiers
- Have new quantity or dosing limits
- Require prior authorization and/or step therapy
- Be added to the list of covered medications
- Be designated as preferred
Complete details about these changes will be available by August 28, 2024. Check back at that time.
Effective May 15, 2024, Select Diabetes and Weight-Loss Medications No Longer Available Through the Mail Service Pharmacy
Effective May 15, 2024, due to a medication shortage, you won’t be able to fill the following diabetes and weight-loss medications in 90-day supplies through the mail service pharmacy:
Diabetes Medications | Weight-Loss Medications |
• Mounjaro • Trulicity |
• Wegovy • Saxenda |
These medications will continue to be available in 30-day supplies through in-network retail pharmacies. If you fill these medications through the mail service pharmacy, you should have received a letter from CVS Customer Care with more information about the change.
If you want to find an in-network pharmacy that’s convenient to you, sign in to MyBlue, then select Find a Pharmacy under My Medications. You can also call Team Blue Member Service at the number on your ID card.
Questions?
If you have any questions, call CVS Customer Care at 1-877-817-0477 (TTY: 711).
On August 1, 2024, AllianceRx Walgreens Specialty Pharmacy will become Walgreens Specialty Pharmacy
AllianceRx Walgreens Specialty Pharmacy delivers specialty pharmacy services to individuals with complex medical conditions. On August 1, 2024, they’re changing their name to Walgreens Specialty Pharmacy. You don’t need to take any action if you’re currently using this pharmacy. They’ll continue to fill your covered prescriptions — just under a new name.
To reach Walgreens Specialty Pharmacy:
- Phone: 1-888-347-3416
- Fax: 1-877-231-8302
Questions?
If you have any questions, call Team Blue at the Member Service number on your ID card.
Acaria Health Is Leaving Our Specialty Pharmacy Network
On July 1, 2024, Acaria Health will be leaving our specialty pharmacy network.
If you fill your prescriptions through Acaria Health, you can complete your current course of treatment with Acaria Health, but treatments starting on or after July 1, 2024 will need to be filled through through Accredo, AllianceRx Walgreens Pharmacy, or CVS Specialty in order to be covered. If you’re currently using Acaria Health, you should have received a letter from us about next steps.
This change applies to plans with the Blue Cross Blue Shield of Massachusetts formulary, and the Standard Control with Advanced Control Specialty Formulary. For more information about specialty medications, use our Medication Lookup tool.
Questions?
If you have any questions, call Team Blue at the Member Service number on your ID card.
UPDATE - Effective July 1, 2024, Changes to the Standard Control with Advanced Control Specialty Formulary
Effective July 1, 2024, CVS Caremark®', an independent company that administers your pharmacy benefits on behalf of Blue Cross Blue Shield of Massachusetts, is updating their formulary (list of covered medications) for medical plans with the Standard Control with Advanced Control Specialty Formulary (SC-ACSF). As part of this update, certain medications may:
- No longer be covered (exceptions may be granted)
- Switch tiers
- Have new quantity or dosing limits
- Require prior authorization and/or step therapy
- Be added to the list of covered medications
- Be designated as preferred
To see the SC-ACSF changes and current medication lists, go to the Medication Lookup tool.
Effective July 1, 2024, Upcoming Changes to the Standard Control with Advanced Control Specialty Formulary
Effective July 1, 2024, CVS Caremark®', an independent company that administers your pharmacy benefits on behalf of Blue Cross Blue Shield of Massachusetts, is updating their formulary (list of covered medications) for medical plans with the Standard Control with Advanced Control Specialty Formulary. As part of this update, certain medications may:
- No longer be covered (exceptions may be granted)
- Switch tiers
- Have new quantity or dosing limits
- Require prior authorization and/or step therapy
- Be added to the list of covered medications
- Be designated as preferred
Complete details about these changes will be available by May 31, 2024. Check back at that time.
UPDATE - Effective April 1, 2024, Upcoming Changes to the Standard Control with Advanced Control Specialty Formulary
Effective April 1, 2024, CVS Caremark®', an independent company that administers your pharmacy benefits on behalf of Blue Cross Blue Shield of Massachusetts, is updating their formulary (list of covered medications) for medical plans with the Standard Control with Advanced Control Specialty Formulary (SC-ACSF). As part of this update, certain medications may:
- No longer be covered (exceptions may be granted)
- Switch tiers
- Have new quantity or dosing limits
- Require prior authorization and/or step therapy
- Be added to the list of covered medications
- Be designated as preferred
To see the SC-ACSF changes and current medication lists, go to the Medication Lookup tool.
Effective April 1, 2024, Upcoming Changes to the Standard Control with Advanced Control Specialty Formulary
Effective April 1, 2024, CVS Caremark®', an independent company that administers your pharmacy benefits on behalf of Blue Cross Blue Shield of Massachusetts, is updating their formulary (list of covered medications) for medical plans with the Standard Control with Advanced Control Specialty Formulary. As part of this update, certain medications may:
- No longer be covered (exceptions may be granted)
- Switch tiers
- Have new quantity or dosing limits
- Require prior authorization and/or step therapy
- Be added to the list of covered medications
- Be designated as preferred
Complete details about these changes will be available by February 28, 2024. Check back at that time.
AllianceRx Walgreens Pharmacy Will Join Our Specialty Pharmacy Network
On January 1, 2024, AllianceRx Walgreens Pharmacy will join our specialty pharmacy network. Specialty pharmacies provide medications that are used to treat certain complex health conditions. For more information about specialty medications, use our Medication Lookup tool.
This change applies to plans with the Blue Cross Blue Shield of Massachusetts Formulary, and the Standard Control with Advanced Control Specialty Formulary.
Questions?
If you have any questions, call Team Blue at the Member Service number on your ID card.
UPDATE - Effective January 1, 2024, Upcoming Changes to the Standard Control with Advanced Control Specialty Formulary
Effective January 1, 2024, CVS Caremark®', an independent company that administers your pharmacy benefits on behalf of Blue Cross Blue Shield of Massachusetts, is updating their formulary (list of covered medications) for medical plans with the Standard Control with Advanced Control Specialty Formulary (SC-ACSF). As part of this update, certain medications may:
- No longer be covered (exceptions may be granted)
- Switch tiers
- Have new quantity or dosing limits
- Require prior authorization and/or step therapy
- Be added to the list of covered medications
- Be designated as preferred
To see the SC-ACSF changes and current medication lists, go to the Medication Lookup tool.
Effective January 1, 2024, Upcoming Changes to the Standard Control with Advanced Control Specialty Formulary
Effective January 1, 2024, CVS Caremark®', an independent company that administers your pharmacy benefits on behalf of Blue Cross Blue Shield of Massachusetts, is updating their formulary (list of covered medications) for medical plans with the Standard Control with Advanced Control Specialty Formulary. As part of this update, certain medications may:
- No longer be covered (exceptions may be granted)
- Switch tiers
- Have new quantity or dosing limits
- Require prior authorization and/or step therapy
- Be added to the list of covered medications
- Be designated as preferred
Complete details about these changes will be available by October 31, 2023. Check back at that time.
UPDATE - Effective January 1, 2024, Upcoming Changes to the Standard Control with Advanced Control Specialty Formulary
Effective January 1, 2024, CVS Caremark®', an independent company that administers your pharmacy benefits on behalf of Blue Cross Blue Shield of Massachusetts, is updating their formulary (list of covered medications) for medical plans with the Standard Control with Advanced Control Specialty Formulary (SC-ACSF). As part of this update, certain medications may:
- No longer be covered (exceptions may be granted)
- Switch tiers
- Have new quantity or dosing limits
- Require prior authorization and/or step therapy
- Be added to the list of covered medications
- Be designated as preferred
To see the SC-ACSF changes and current medication lists, go to the Medication Lookup tool.
Effective January 1, 2024, Upcoming Changes to the Standard Control with Advanced Control Specialty Formulary
Effective January 1, 2024, CVS Caremark®', an independent company that administers your pharmacy benefits on behalf of Blue Cross Blue Shield of Massachusetts, is updating their formulary (list of covered medications) for medical plans with the Standard Control with Advanced Control Specialty Formulary. As part of this update, certain medications may:
- No longer be covered (exceptions may be granted)
- Switch tiers
- Have new quantity or dosing limits
- Require prior authorization and/or step therapy
- Be added to the list of covered medications
- Be designated as preferred
Complete details about these changes will be available by October 31, 2023. Check back at that time.
UPDATE - Effective October 1, 2023, Upcoming Changes to the Standard Control with Advanced Control Specialty Formulary
Effective October 1, 2023, CVS Caremark®', an independent company that administers your pharmacy benefits on behalf of Blue Cross Blue Shield of Massachusetts, is updating their formulary (list of covered medications) for medical plans with the Standard Control with Advanced Control Specialty Formulary (SC-ACSF). As part of this update, certain medications may:
- No longer be covered (exceptions may be granted)
- Switch tiers
- Have new quantity or dosing limits
- Require prior authorization and/or step therapy
- Be added to the list of covered medications
- Be designated as preferred
To see the SC-ACSF changes and current medication lists, go to the Medication Lookup tool.
Effective October 1, 2023, Upcoming Changes to the Standard Control with Advanced Control Specialty Formulary
Effective October 1, 2023, CVS Caremark®', an independent company that administers your pharmacy benefits on behalf of Blue Cross Blue Shield of Massachusetts, is updating their formulary (list of covered medications) for medical plans with the Standard Control with Advanced Control Specialty Formulary. As part of this update, certain medications may:
- No longer be covered (exceptions may be granted)
- Switch tiers
- Have new quantity or dosing limits
- Require prior authorization and/or step therapy
- Be added to the list of covered medications
- Be designated as preferred
Complete details about these changes will be available by August 31, 2023. Check back at that time.
UPDATE - Effective July 1, 2023, Upcoming Changes to the Standard Control with Advanced Control Specialty Formulary
Effective July 1, 2023, CVS Caremark®', an independent company that administers your pharmacy benefits on behalf of Blue Cross Blue Shield of Massachusetts, is updating their formulary (list of covered medications) for medical plans with the Standard Control with Advanced Control Specialty Formulary (SC-ACSF). As part of this update, certain medications may:
- No longer be covered (exceptions may be granted)
- Switch tiers
- Have new quantity or dosing limits
- Require prior authorization and/or step therapy
- Be added to the list of covered medications
- Be designated as preferred
To see the SC-ACSF changes and current medication lists, go to the Medication Lookup tool.
Effective July 1, 2023, Upcoming Changes to the Standard Control with Advanced Control Specialty Formulary
Effective July 1, 2023, CVS Caremark®', an independent company that administers your pharmacy benefits on behalf of Blue Cross Blue Shield of Massachusetts, is updating their formulary (list of covered medications) for medical plans with the Standard Control with Advanced Control Specialty Formulary. As part of this update, certain medications may:
- No longer be covered (exceptions may be granted)
- Switch tiers
- Have new quantity or dosing limits
- Require prior authorization and/or step therapy
- Be added to the list of covered medications
- Be designated as preferred
Complete details about these changes will be available by May 31, 2023. Check back at that time.
UPDATE - Effective April 1, 2023, Upcoming Changes to the Standard Control with Advanced Control Specialty Formulary
Effective April 1, 2023, CVS Caremark®', an independent company that administers your pharmacy benefits on behalf of Blue Cross Blue Shield of Massachusetts, is updating their formulary (list of covered medications) for medical plans with the Standard Control with Advanced Control Specialty Formulary (SC-ACSF). As part of this update, certain medications may:
- No longer be covered (exceptions may be granted)
- Switch tiers
- Have new quantity or dosing limits
- Require prior authorization and/or step therapy
- Be added to the list of covered medications
- Be designated as preferred
To see the SC-ACSF changes and current medication lists, go to the Medication Lookup tool.
Effective April 1, 2023, Upcoming Changes to the Standard Control with Advanced Control Specialty Formulary
Effective April 1, 2023, CVS Caremark®', an independent company that administers your pharmacy benefits on behalf of Blue Cross Blue Shield of Massachusetts, is updating their formulary (list of covered medications) for medical plans with the Standard Control with Advanced Control Specialty Formulary. As part of this update, certain medications may:
- No longer be covered (exceptions may be granted)
- Switch tiers
- Have new quantity or dosing limits
- Require prior authorization and/or step therapy
- Be added to the list of covered medications
- Be designated as preferred
Complete details about these changes will be available by February 28, 2023. Check back at that time.
Effective January 1, 2023, Medications Covered by the Standard Control with Advanced Control Specialty Formulary
The following medication lists include medications that are covered and non-covered by the Standard Control with Advanced Control Specialty Formulary (SC-ACSF), effective January 1, 2023. The SC-ACSF will be administered by CVS Caremark®´, an independent company that administers your pharmacy benefits on behalf of Blue Cross Blue Shield of Massachusetts.
View 2023 Comprehensive Covered Medication List
View 2023 Comprehensive Drug Removal List
CaremarkPCS Health, LLC (“CVS Caremark”) is an independent company that has been contracted to administer pharmacy benefits and provide certain pharmacy services for Blue Cross Blue Shield of Massachusetts. CVS Caremark is part of the CVS Health family of companies. Blue Cross Blue Shield of Massachusetts is an Independent Licensee of the Blue Cross and Blue Shield Association.
Encompass Fertility™ Has Joined Our Specialty Pharmacy Network for Fertility Medications
Effective July 19, 2022, Encompass Fertility has joined our specialty pharmacy network for fertility medications. They have access to all our covered fertility medications, and they can fill and ship medications in all 50 states.
This change applies to plans with the Blue Cross Blue Shield of Massachusetts formulary, and the National Preferred Formulary (NPF). For more information about specialty fertility medications, use our Medication Lookup tool.
Questions?
If you have any questions, call Team Blue at the Member Service number on the front of your ID card.
Metro Drugs Is Leaving Our Specialty Pharmacy Network for Fertility Medications
Effective May 1, 2022, Metro Drugs, a fertility medication pharmacy, will be leaving our specialty pharmacy network. If you’re taking fertility medications and fill your prescriptions through Metro Drugs, you’ll be able to complete your current course of treatment with Metro Drugs, but treatments starting after May 1, 2022 will need to be filled through Freedom Fertility Pharmacy, or Village Fertility Pharmacy in order to be covered. If you’re currently using Metro Drugs, you’ll receive a letter from us about next steps.
This change applies to plans with the Blue Cross Blue Shield of Massachusetts formulary, and the National Preferred Formulary (NPF). For more information about specialty fertility medications, use our Medication Lookup tool.
Questions?
If you have any questions, call Team Blue at the Member Service number on the front of your ID card.
Effective July 1, 2022, Medications No Longer Covered Under the National Preferred Formulary
Effective July 1, 2022, Express Scripts, Inc.®´, an independent company that administers your pharmacy benefits on behalf of Blue Cross Blue Shield of Massachusetts, is updating their formulary (list of covered medications) for medical plans with the National Preferred Formulary (NPF). Included in this update are medications that will no longer be covered under the NPF.
After carefully reviewing each medication’s cost and its clinically appropriate covered alternatives, Express Scripts is removing medications from their formulary. However, a doctor may request an exception if these medications are medically necessary. If the exception is approved by Blue Cross, you’ll pay the highest-tier cost.
Effective January 1, 2022, Medications No Longer Covered Under the National Preferred Formulary
Beginning January 1, 2022, Express Scripts, Inc.®´, an independent company that administers your pharmacy benefits on behalf of Blue Cross Blue Shield of Massachusetts, is updating their formulary (list of covered medications) for medical plans with the National Preferred Formulary (NPF). Included in this update are medications that will no longer be covered under the NPF.
After carefully reviewing each medication’s cost and its clinically appropriate covered alternatives, Express Scripts has removed medications from their formulary. However, a doctor may request an exception if these medications are medically necessary. If the exception is approved by Blue Cross, you’ll pay the highest-tier cost.
Effective July 1, 2021, Medications No Longer Covered Under the National Preferred Formulary
Beginning July 1, 2021, Express Scripts, Inc.®´, an independent company that administers your pharmacy benefits on behalf of Blue Cross Blue Shield of Massachusetts, is updating their formulary (list of covered medications) for medical plans with the National Preferred Formulary. Included in this update are medications that will no longer be covered under the National Preferred Formulary.
After carefully reviewing each medication’s cost and its clinically appropriate covered alternatives, Express Scripts has removed medications from their formulary. However, a doctor may request an exception if these medications are medically necessary. If the exception is approved by Blue Cross, you’ll pay the highest-tier cost.
Upcoming Coverage Changes for Certain Medications Moving from Our Medical to Pharmacy Benefit
Effective July 1, 2021, coverage for the following medications will move out of our medical benefit and only be included under our pharmacy benefit. This change will apply to all medical plans, except Managed Blue for Seniors, group Medicare Advantage, group Medex®´, and Federal Employee Program plans.
Medications Moving from Our Medical to Pharmacy Benefit | |||
---|---|---|---|
Available at Retail Pharmacies | Durolane* | Gel-One* | GelSyn-3* |
Monovisc* | Triluron* | Trivisc* | |
Must Be Filled at a Specialty Pharmacy | Bynfezia | Cosentyx* | Dupixent* |
Fasenra* | Kevzara* | Nucala* | |
Siliq* | Strensiq | Tegsedi* | |
Tremfya* |
Members who have plans with the Blue Cross Blue Shield of Massachusetts formulary, as well as Medex®’ plans** with a three-tier pharmacy benefit, or the National Preferred Formulary*** will receive coverage for these medications under their pharmacy benefit upon the effective date. Members with these plans will not experience a break in coverage as these medications move from the medical benefit to the pharmacy benefit. Group Medex plans with a three-tier pharmacy benefit will include coverage for these medications under both the medical and pharmacy benefit. If you don’t have pharmacy coverage from Blue Cross Blue Shield of Massachusetts, refer to your pharmacy plan benefit materials for coverage details on these medications.
If affected, we’ll contact you about this change and help you transition your prescription to support uninterrupted coverage.
This change doesn’t apply when these medications are administered in inpatient, surgical day care, ambulatory surgery center, and emergency department settings.
Questions?
For more information, call Team Blue at the Member Service number on your ID card.
*These medications require prior authorization.
**This doesn’t include Medex 2 plans with Blue MedicareRx (PDP) prescription drug coverage.
***Plans with the National Preferred Formulary may have additional coverage requirements for these medications.
Changes to Our Specialty Pharmacy Network for Fertility Medications
Beginning August 31, 2020, AcariaHealth™ Fertility will no longer participate in our specialty pharmacy network for fertility medications. This change applies to plans with the Blue Cross Blue Shield of Massachusetts formulary, and the National Preferred Formulary (NPF).
Members will be able to complete their current course of treatment with AcariaHealth Fertility; however, specialty fertility medications purchased through AcariaHealth Fertility after August 31, 2020, will no longer be covered. We’ll contact members who fill their prescriptions at AcariaHealth Fertility to let them know that the pharmacy is leaving our specialty fertility network, and help them transition to another in-network specialty pharmacy for fertility medications. This change only applies to AcariaHealth Fertility and our specialty fertility network. AcariaHealth Fertility’s parent company, AcariaHealth, will remain in our specialty pharmacy network.
Specialty pharmacies provide specialty medications that are used to treat certain complex health conditions. For more information about specialty medications, use our Medication Lookup tool.
If you have any questions, please call Member Service at the number on the front of your ID card.
Coverage Update for Truvada
On July 1, 2020, we’ll begin covering Truvada, an HIV pre-exposure prophylaxis (PrEP) medication, at no additional cost for members who aren’t currently filling other HIV medications. Members taking other HIV medications, or are switching from an HIV medication to Truvada, will have to pay their usual out-of-pocket costs, including copays, co-insurance, and deductibles. This change applies to new prescriptions and refills, and to plans with either the Blue Cross Blue Shield of Massachusetts Formulary or National Preferred Formulary. However, the change doesn’t apply to grandfathered plans that don’t comply with the Affordable Care Act.
When the generic version of Truvada is released, we’ll start covering the generic version (instead of Truvada) at no additional cost for members who aren’t currently filling other HIV medications. At that time, members who continue to take Truvada, whether they’re taking additional HIV medications or not, will have to pay their usual out-of-pocket costs, including copays, co-insurance, and deductibles.
If you have any questions, please call Member Service at the number on the front of your ID card.
Coverage Change for Breast Cancer Risk-Reduction Medications
On October 1, 2020, we’ll begin covering the following generic oral medications in the class of aromatase inhibitors at no additional cost for members when the medications are prescribed to reduce breast cancer risk:
- Anastrozole
- Exemestane
- Letrozole
This change applies to plans with either the Blue Cross Blue Shield of Massachusetts Formulary or the National Preferred Formulary. However, this change doesn’t apply to grandfathered plans that don’t comply with the Affordable Care Act.
If you have any questions, please call Member Service at the number on the front of your ID card.
Changes to our speciality pharmacy network
Beginning March 31, 2020, BriovaRx®'' will no longer participate in our specialty pharmacy network. This change applies to the Blue Cross Blue Shield of Massachusetts formulary, and the National Preferred Formulary (NPF). This doesn't affect members who have Medicare Advantage with a Part D prescription drug plan; they can continue to use BriovaRx without interruption.
Unless you have Medicare Advantage with a Part D plan, you’ll no longer be covered for specialty medications purchased through BriovaRx. We’ll contact members who fill their prescriptions at BriovaRx to let them know that the pharmacy has left our network, and help them transition to an in-network specialty pharmacy.
Specialty pharmacies provide specialty medications that are used to treat certain complex health conditions. For more information about specialty medications, use the Medication Lookup tool.
If you have any questions, please call Member Service at the number on the front of your ID card.